AMYRIS ANNOUNCES OPERATIONAL AND FINANCIAL RESTRUCTURING TO ADVANCE STRATEGIC TRANSFORMATION
- Voluntary Chapter 11 Commenced to Finalize Consensual Go-Forward Plan for Amyris' Core Business $190 Million Financing Commitment from Foris Ventures to Support Day-to-Day Operations EMERYVILLE, Calif. , Aug. 9, 2023 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS) ("Amyris" or the "Company"), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform and clean beauty consumer brands, today announced that it is moving forward with an operational and financial restructuring to further advance its ongoing strategic transformation and position the Company for long-term success.
- 08/09/2023
|
Amyris Warns Of Potential Bankruptcy - Sell
- Cash-strapped specialty renewable products developer Amyris remains on life support by largest shareholder and creditor John Doerr. In recent months, Doerr has provided another $157.5 million in secured debt financing thus increasing his total secured debtholdings to $290 million with more likely to come. Last week, the company warned investors of a potential in-court restructuring as part of its ongoing restructuring efforts.
- 08/07/2023
|
7 Biotech Stocks to Sell in July
- Biotech may be a great sector for risk-seeking investors to find opportunity. That said, for every biotech stock worth buying, there are plenty that fit into the “biotech stocks to sell” category.
- 07/13/2023
|
Is It Time to Buy This Year's Worst-Performing Growth Stocks?
- Not all low-priced stocks are appealing for investment, as some remain too unpredictable even at a lower buy-in price. This is a mixed bag and investors should do a deep analysis before investing in market-lagging growth stocks.
- 07/11/2023
|
Amyris: CEO's Exit Has Negative Implications
- The resignation of Amyris' CEO is likely to be viewed as a positive by many, but the implications of this are negative. Management turnover and the engagement of a consulting firm are not signs of a healthy business. Poor communication with shareholders also remains an issue. The company is reportedly trying to cut costs, but its efforts may not be as aggressive as necessary.
- 07/03/2023
|
10 Top Penny Stocks To Watch Right Now For Under $1
- Welcome to the world of penny stocks. This is a corner of the stock market that piques interest and raises eyebrows in equal measure.
- 06/29/2023
|
Amyris: Company Separates From Long-Standing CEO Amid Ongoing Restructuring Efforts - Sell
- Earlier this month, cash-strapped specialty renewable products developer Amyris announced a strategic transformation program to improve the company's cost and capital structure and liquidity. Secured debtholders agreed to amend the terms of existing credit facilities and waive existing defaults. The company also secured up to $50 million in additional loan commitments from Anesma Group LLC, an entity affiliated with director and largest shareholder John Doerr.
- 06/27/2023
|
Arctic Marine Response Station in Rankin Inlet open for the season
- YELLOWKNIFE, NT, June 23, 2023 /CNW/ – The Canadian Coast Guard’s Arctic Marine Response Station (AMRS) in Rankin Inlet, Nunavut is now open for the season. The Arctic Marine Response Station, formerly known as the Inshore Rescue Boat (IRB) North station, first opened in 2018, establishing it as the first Canadian Coast Guard (CCG) search […]...
- 06/23/2023
|
3 Hot Penny Stocks To Watch Before Next Week
- Penny stocks typically trade for less than $5 and generally belong to small companies often overlooked by mainstream investors. Yet, for those willing to navigate the inherent risks, these cheap stocks can offer a world of potential.
- 06/07/2023
|
3 Penny Stocks Under $1 To Watch This Week; Time To Buy?
- In the diverse financial market landscape, penny stocks hold a unique position. These low-priced shares, typically trading for less than $5 as defined by the U.S. Securities and Exchange Commission, usually belong to small companies that often go unnoticed by mainstream investors.
- 06/06/2023
|
Hot Penny Stocks To Watch After UCAR Stock Explodes
- If there's one thing we know now it's that catalysts play a significant role in trading penny stocks. This is where things like sympathy sentiment can play a much larger role.
- 06/01/2023
|
OTTO Motors Unveils North American Sales and Service Expansion With OTTO Certified Dealers
- KITCHENER, Ontario--(BUSINESS WIRE)--OTTO Motors, a leading provider of autonomous mobile robots (AMRs), today announced the launch of the OTTO Certified Dealer program to provide high-quality service and support locally throughout North America. The program introduces over 215 regional offices and 2,000 technicians to the rapidly-growing AMR industry. To meet the rising demand for AMRs, OTTO Motors has trained and certified the most reputable material handling equipment organizations to deliver solutions with the same quality that OTTO Motors is known for. “Customers demand exceptional service. We’ve built our OTTO Certified Dealer program like we’ve built our products, with unwavering emphasis on quality to ensure that our customers receive the exceptional service they expect,” said John Stikes, Director of Global Strategic Alliances and Partnerships at OTTO Motors. Dan Gill, Head of Dealer Relations at OTTO Motors, added: “We have hand-selected the top material handling equipment organizations in the continent to locally deliver the technical support and maintenance needed to deploy, maintain and scale automation systems.” Every OTTO Certified Dealer facilitates an outstanding customer experience and boasts a well-trained team, highly competent at designing, installing and maintaining AMR solutions. They have successfully completed an intensive program to ensure they deliver best-in-class service. "OTTO Motors offers user-friendly, cutting-edge solutions that allow us to minimize disruption at our customer's facilities while building that return on investment from day one," said Jason Dodge, Automation Manager of Eastern Lift Truck Co., Inc. "We look forward to our continued partnership with OTTO Motors and solving a wide variety of material handling challenges across North America." Combining more than 580 years of material handling experience, OTTO Certified Dealers include: Distribuidora LARCE: LARCE is a leading provider of industrial equipment solutions in Costa Rica since 1949, dedicated to promoting the development of the industrial sector by offering the latest in technology, advice and after-sales service. Eastern Lift Truck (ELT) Systems Group: With over 20 locations across the eastern United States, ELT Systems Group provides end-to-end manufacturing automation and robotic solutions, material handling equipment and installation technicians to service facilities nationwide. MH Equipment: MH Equipment is one of the largest and fastest-growing material handling service providers in the United States, helping their customers maximize ROI, stay on top of equipment maintenance, and manage fleets across multiple locations. Papé Material Handling: Papé has built a legacy from providing uptime to customers and serving consistent, quality customer service for over 85 years. With 39 full service locations in 6 states across the western United States, their experienced team members are available 24/7 and committed to “keep you moving.” Toyota Material Handling Systems: TMHS has built their foundation on exceptional customer satisfaction, offering tailored end-to-end solutions that help customers improve productivity across their warehousing, logistics, manufacturing, distribution and supply chain operations. For more information on OTTO Certified Dealers, visit ottomotors.com/certified-network About OTTO Motors OTTO Motors provides autonomous mobile robots for material handling inside manufacturing facilities and warehouses. With over four million hours of driving experience, OTTO is trusted for mission-critical deliveries in the most demanding of industrial environments. The leading AMR provider was recently recognized as a top 10 global robotics provider, named to Fast Company’s 2023 list of Most Innovative Companies. Seventy percent of OTTO’s customers are Fortune 500 companies and include some of the world’s most recognized brands, including GE and Toyota. For more information, visit ottomotors.com.
- 05/23/2023
|
Big Joe Debuts New AMR Features & Capabilities at Automate 2023
- DETROIT--(BUSINESS WIRE)--Big Joe Forklifts has seen tremendous response to its recently launched Pallet Mover, a new user-directed autonomous mobile robot (AMR), and is showing off its newest features at Automate 2023. Developed in partnership with Thoro.ai, the Big Joe Pallet Mover is an easy-to-deploy autonomous solution for floor-to-floor pallet transportation and drop-off that companies can set up and begin operating in less than one hour after receipt. New Pallet Mover AMR features that will be introduced at Automate 2023 include dynamic mapping, map sharing, and zone drop functionality to further enhance the product’s capabilities and thereby increase potential use cases and return on investment for customers. Dynamic mapping allows the Big Joe Pallet Mover to update onboard facility maps on the fly to keep up with changing environments and thus reduces map depreciation and the need to frequently remap areas of operation. As multiple Pallet Movers working in the same facility adapt to changes, users can now utilize a new map sharing feature via Wi-Fi to update all units and efficiently maintain performance across a fleet. “AMRs bring so many benefits to the modern warehouse, and The Pallet Mover from Big Joe offers functionality, dependability and a point of entry to automation that doesn’t require any enterprise-wide software or extensive training to get up and running,” said Big Joe’s Chief Marketing Officer, Bill Pedriana. “With the new features being released this week and our simple implementation process, our focus remains on empowering workers and eliminating the need for complicated systems integration.” In addition to enhanced mapping capabilities, the new zone drop feature being introduced at Automate 2023 greatly enhances the Pallet Movers ability to do what it does best. That is to autonomously travel to a destination and deliver pallets to preset locations. When the zone drop feature is used, the Pallet Mover will take a load to a predefined area in a facility having multiple pallet delivery locations and will place a pallet in the first open spot based on sequential order – even if they are not in one continuous row or adjacent to one another. “Given my experience vetting manufacturers that have begun adopting autonomous technology, I can tell you first-hand that the new features we are introducing will eliminate a lot of severe headaches and cost for our customers,” said Big Joe’s Autonomous Division General Manager Nick Malewicki. “None of my suppliers when I was a customer of automation could deal with the high level of change in areas like receiving docks without need of hard infrastructure or an industrial engineer being regularly involved. Our focus on making this machine as easy to deploy as it is to use and where we are at with these new features is such a huge step change from where the industry has been stuck for years.” The Big Joe Pallet Mover features an intuitive tablet interface, LiDAR, and a camera system to transport and drop pallets to locations autonomously once the operator initiates it and selects a mission. This collaborative approach uses self-driving technology as a productivity force multiplier by allowing workers to focus on higher-value tasks or direct multiple independent workflows concurrently. Initial pricing for the Pallet Mover is set at $65,000 plus tax and freight per unit inclusive of deployment, initial training and a robust three-year autonomous software and support subscription. To learn more about specs and additional features, or to test drive the Big Joe Pallet Mover at your facility, contact Big Joe or your local dealer for more information. About Big Joe For more than 70 years, Big Joe electric forklifts have been the standard of quality in factories, warehouses, DCs and storerooms across the USA and around the world. Big Joe’s walkie stackers, pallet trucks and access vehicles are well known for their rugged, easy-to-use designs that provide a low-cost alternative to traditional forklifts. Big Joe’s new lithium-ion sit-down forklifts and autonomous mobile robots carry forward the legacy of the brand by empowering workers with new technologies in a simple and intuitive way to both move more and hurt less. For more information, visit bigjoeforklifts.com or follow us on social media.
- 05/22/2023
|
Melonee Wise Joins Agility Robotics as CTO in Leadership Team Expansion
- CORVALLIS, Ore.--(BUSINESS WIRE)--Agility Robotics today announced a significant expansion to the company’s leadership team. Effective immediately, the following distinguished individuals are combining their expertise, experience, and passion to work on Digit, the first human-centric, multi-purpose robot made for work, starting with deployments in the logistics industry. Renuka Ayer, Chief Financial Officer (joined October 2022) Rich Bohne, Chief Commercial Officer (joined June 2022) Aindrea Campbell, Chief Operations Officer (joined January 2023) Liz Clinkenbeard, VP of Communications (joined December 2022) Pras Velegapudi, VP of Innovation and Distinguished Engineer (joined May 2023) Melonee Wise, Chief Technology Officer (joined May 2023) An additional update to Agility’s leadership structure is the development of the new Chief Robot Officer (CRO) organization, to be led by co-founder Jonathan Hurst. Jonathan’s groundbreaking bipedal locomotion research is the basis on which Agility was created. Jonathan’s passion has always been in research, innovation, and setting the vision for how Agility’s robots should look, move, function, and interact with the world. He has therefore transitioned his title from CTO to CRO, to more closely match with his day-to-day work: setting Agility’s research and development roadmap, cultivating the innovation pipeline, shepherding Digit’s industrial design, and nurturing the company’s overall brand identity. This change also allowed Agility to open a new CTO role focused on Digit, the broader software product, and fleet deployment technologies, ultimately paving the way for Melonee Wise to join. Growing The Leadership Team with Accomplished Talent “Agility has had a great deal of highlights recently, but perhaps the most significant is the strategic growth of our leadership team over the past year and the addition of game-changing expertise that will position Agility for long-term success,” according to Damion Shelton, CEO of Agility Robotics. “We’ve recently added a CCO, CFO, and COO, and created the exciting new CRO organization led by my co-founder Jonathan Hurst. Today, we’re thrilled to cap off this incredible year of leadership growth by welcoming industry luminary and well-known roboticist Melonee Wise to the team as our new CTO.” Melonee Wise, Chief Technology Officer: The most recent addition to the Agility executive team, Melonee brings as much (or more) experience in building and deploying robot fleets than just about anyone on the planet. Among many other accomplishments, Melonee is the recipient of the 2022 Engelberger Robotics Award, the world’s most prestigious robotics honor. Prior to joining Agility, Melonee was Vice President and General Manager of Robotics Automation for Zebra Technologies. In 2021, Zebra acquired Fetch Robotics, which Melonee co-founded, and for whom she served as CEO from the company’s formation in 2015. As CEO of Fetch Robotics, Melonee moved the Autonomous Mobile Robot (AMR) market forward through her expertise in hardware and software. Melonee was also a driving force behind the first-ever safety certification for AMRs. Melonee will be a catalyst for Agility’s broader software and technology systems for deploying fleets of Digits in warehouses all over the country. Pras Velegapudi, VP of Innovation and Distinguished Engineer: Agility’s new Innovation Department will be home to the company’s technology strategy and research & development efforts. Pras is uniquely qualified for this role, with decades of experience in robotics planning & control, creating and deploying robots into home, industrial, and outdoor environments around the world. He was most recently Chief Architect at Berkshire Grey, applying fleets of hundreds of robots in logistics applications. In a landscape that is constantly disrupted by new technology, Pras will be focused on pragmatic product-relevant innovations, driven by the vision and strategy for Digit. Renuka Ayer, Chief Financial Officer: Renuka has a long and storied career in finance, M&A, and strategic leadership at public and private companies such as Glowforge, Pulse Electronics, Dover, and Ford to name a few. She also has a strong track record of taking companies from startup to growth stage and beyond. She instantly transformed Agility into a more robust and mature company, ensuring that the company makes the right financial decisions to secure a long and profitable future. Rich Bohne, Chief Commercial Officer: Rich brings thirty years of sales, leadership, and commercial growth experience, most recently as Chief Revenue Officer at Fetch Robotics where he led the global sales team prior to the successful acquisition by Zebra Technologies. Rich is the champion of Agility’s commercial partnerships. With his expertise, Agility has already launched the Agility Partner Program and attracted multiple new Fortune 100 customers. Aindrea Campbell, Chief Operations Officer: With more than twenty years as a senior operations leader at companies including Ford and Apple, Aindrea’s resume pretty much speaks for itself. Aindrea brings deep experience in transformation–including co-leading the transition from steel to aluminum on the F150 and rapidly scaling capacity as head of iPad operations during COVID. Aindrea brings an expert vision for product development and manufacturing. With Aindrea’s guidance, Agility will continue rapidly scaling its manufacturing and corporate operations to meet the large commercial demand for Digit. Liz Clinkenbeard, VP of Communications: Liz owns Agility’s public image, storytelling, and brand. Liz is working closely with Jonathan Hurst to establish Digit’s persona and design, and to share Agility's vision of enabling humans to be more human. Liz has a long and distinguished career in technology communications and marketing, leading communications at GitHub, managing some of the largest technology brands in the world during her tenure at The Outcast Agency, and most recently co-founding and successfully growing Chatterbug, an online language-learning startup. Liz has the creative vision and expertise to position Agility as one of the world's most well-known, innovative, and respected robotics brands. About Agility Robotics Co-headquartered in Corvallis, Oregon and Pittsburgh, Pennsylvania, with offices in Palo Alto, California, Agility Robotics’ mission is to build robot partners that augment the human workforce, ultimately enabling humans to be more human™. Agility’s groundbreaking bi-pedal robot Digit is the first multi-purpose, human-centric robot that is made for work™.
- 05/22/2023
|
Amyris (AMRS) Q1 Earnings In Line, Revenues Beat Estimates
- Amyris (AMRS) sees lower sales in its Consumer and Technology Access segments in the first quarter.
- 05/19/2023
|
MiR Features Latest Innovations in Autonomous Mobile Robots at Automate 2023
- DETROIT--(BUSINESS WIRE)--Mobile Industrial Robots (MiR), the global market leader in autonomous mobile robots (AMRs), will feature the company’s latest safe, flexible and cost-effective AMRs as well as advancements in fleet management software and artificial intelligence (AI) at Automate 2023 in Detroit May 22-25. Attendees can see MiR’s full range of AMRs for automating internal logistics in manufacturing and warehouse environments, experience how its new MiR Insights optimizes fleets of robots and hear about the role AI plays (or will soon play) in unlocking the value of AMRs for any operation. “Advancements in AMRs, from artificial intelligence to fleet management and data analysis capabilities, make the decision to automate or expand robot fleets to handle new applications easy while delivering increased efficiencies and faster ROI,” said Jane Heffner, director of sales, Americas. “Seeing our user-friendly and highly flexible robots in person—whether in limited motion at the booth or full out in the AMR Technology Demonstration booth—makes it clear how they can benefit nearly any organization. It’s what keeps our customers, especially some of the largest multinational enterprises worldwide, coming back for more AMRs to handle even more logistics applications within their facilities.” AMRs and how MiR Insights help optimize fleets In addition to AMRs at its booth (#4032), MiR will offer expanded demonstrations at the AMR Technology Demonstration Center (#450) May 22 from 1 p.m. to 1:30 p.m. and May 24 from 3:15 p.m. to 3:45 p.m. Featured AMRs include the MiR250, capable of transporting materials up to 250 kg (551 pounds), along with the MIR600 and MiR1350, the first IP52-rated AMRs designed for transporting heavy materials through challenging manufacturing and logistic warehouse environments. As demonstrated, MiR’s AMRs navigate smoothly and safely among people and other transport equipment in dynamic environments, even on busy trade show floor. Sensors, 3D cameras and the latest laser scanning technology ensure 360-degree vision for precise and safe navigation and operations. MiR will also feature, upon request, an in-depth video demonstration of the company’s newest software tools suite, MiR Insights, in operation at a customer facility. This cloud-based software tool enables fleet owners to track and analyze the operations of its robots and get actionable insights that can improve the robots’ performance. Key features include: Data dashboards: Monitors key performance indicators (KPIs) such as distance driven, completed missions, and robot utilization rate. Heatmaps: Tracks robot activity over both time and physical locations and visualizes areas with poor WiFi coverage and potential robot traffic bottlenecks. Learn how artificial intelligence accelerates AMR deployments With AI dominating the headlines, MiR chief architect, James Davidson, will share conference session on “AI for AMRs: A synergistic approach to unlocking the value of autonomous mobile robots for your operation.” Scheduled for Monday, May 22, from 2:30 p.m. to 3:15 p.m., in room 320 of the conference, Davidson will simplify the conversation around AI and zoom in specifically on the landscape of AMRs, highlighting how AI is (or soon will be) unlocking incremental value for a company’s operations. “Adopting AMRs into wide-scale operations is still in its infancy, and artificial intelligence could well be the critical component needed to accelerate adoption worldwide,” Davidson said. “While AI has developed into somewhat of an abstract and confusing ‘buzzword’ across all industries, the potential is. massive and wide-reaching, and real-world use cases with AMRs already demonstrate the benefits AI can offer.” Partners expand MiR AMR demonstrations across the show floor In addition to robots in MiR’s booth and the AMR Technology Demonstration Center, partners will feature MiR AMRs as part of their automation solution. MiR AMRs can be found in the following booths: Wauseon Machine (#4439) Alliance Automation (#200) GCG Automation (C&E) (#5520) Rhino (#3752) Motion AI (#1035) Humatics (#5415) Applied Automation (#4039) About Mobile Industrial Robots (MiR) MiR develops and manufactures one of the industry’s most advanced range of autonomous mobile robots (AMRs), which can quickly, easily, and cost-effectively automate internal logistics and optimize material handling. MiR offers one of the most advanced fleets of mobile robots used by both large enterprises and small and medium customers in a range of industries from manufacturing to logistics to healthcare. Founded in Denmark in 2013, MiR has grown to become a global leader with nearly 220 distributors and certified system integrators in 60 countries. MiR was acquired by Teradyne in 2018, and in 2022, Teradyne combined AutoGuide Mobile Robots with MiR to deliver a broad AMR product line from low to heavy payload. MiR’s headquarters is in Odense, Denmark, with regional offices in Holbrook, NY, San Diego, CA, North Reading, MA, Georgetown, KY, Singapore, Frankfurt, Barcelona, Tokyo, Seoul and Shanghai. For more information, visit www.mobile-industrial-robots.com
- 05/18/2023
|
OSARO and Geek+ Partner to Integrate Robotic Warehouse Solutions
- SAN FRANCISCO--(BUSINESS WIRE)--OSARO®, a global leader in machine-learning-enabled robotics for e-commerce, announced a partnership that integrates its pick-and-place robots with groundbreaking Geek+ warehouse automation systems. The new alliance offers businesses a one-stop solution for their warehouse fulfillment operations and a strategy to boost the ROI of their autonomous mobile robot systems (AMRs) and automated storage and retrieval systems (ASRS). “At OSARO, our goal is to provide reliable robotic systems that make automation easy, which is why the seamless integration of our picking robots with Geek+ systems is so valuable for quick and easy deployment,” said OSARO CEO Derik Pridmore. “We’re pleased to have an OSARO-powered robot and Geek+ Sorting Series AMRs available for customers to see in action at our San Francisco RobotWorks customer center.” Robots collaborating The pairing represents another step in the progression of robots working together across the warehouse. It involves the ability to connect Geek+ AMRs and ASRS with OSARO’s smart, AI-driven picking robots. Using a FANUC robot arm, OSARO enables automation of the last step in the warehouse fulfillment process—picking and placing—is a function that until now has been handled solely by human operators at workstations. The easy interoperability of OSARO-powered robots with AMR/ASRS and other warehouse systems is made possible by OSARO’s latest REST API, which offers greater flexibility in what the systems can be asked to do. The API allows integrators to choose commands in a variety of blocks, so that actions can readily be strung together in different ways. For example, a system can be directed to pick, scan, and place an object. Or it can be ordered to pick, scan, and then wait for a customer warehouse management system to send a command before performing an additional action. Scalable and flexible The desire for a complete solution, including the automation of human picking stations, has been accelerated by the triple dilemma of crushing e-commerce demand, the most severe labor shortage in 53 years, and sky-high consumer expectations for lower prices and faster delivery. Together, Geek+ and OSARO can deploy a scalable solution for warehouses needing to address unrelenting growth while keeping costs low, despite inflation. Working in tandem, these two automation leaders offer flexible systems with easy installation that improve accuracy and productivity. Unlike traditional bolted-to-the-floor conveyor systems, Geek+ mobile robots are simple and fast to install or reconfigure, needing only moveable QR code floor marks to operate. “Solving the labor shortage is critical for anyone in e-commerce today,” said Rick DeFiesta, executive vice president of sales and solutions at Geek+ America. “Geek+ systems take less floor space and are highly flexible in both their use and installation, allowing for easy redeployments in new configurations when necessary.” OSARO is now demonstrating integrations with the Geek+ Sorting Series in its San Francisco RobotWorks Customer Center. Customers experience a range of benefits, including: Increased throughput Reduced dependence on labor Faster order processing Greater shipment accuracy Improved ROI A scalable solution for changing needs Less need for floor space As part of the agreement, Geek+ has joined OSARO’s partner program, which offers one-stop access for businesses looking to deploy robotic solutions in their fulfillment operations. The OSARO Partners Alliance provides a mechanism for AMR and ASRS vendors, integrators, distributors, third-party logistics companies, and consultants to collaborate and co-market unified solutions. The program is designed to optimize every stage of a customer’s purchasing and deployment processes, in collaboration with the partners. Learn more about OSARO’s piece-picking robotic solutions Watch the video: Optimize your AMR/ASRS with Smart Robots Visit the OSARO Piece Picking for AMR/ASRS datasheet Learn how smarter robots are reshaping the warehouse Set up a consultation with OSARO’s solutions team OSARO Partners Alliance Advances in Al-driven robotics have created new solutions to tackle supply-chain disruptions and labor shortages and to equip e-commerce operations with end-to-end systems that accelerate delivery and boost productivity. But tailoring the right solution requires a collaborative approach that includes software, hardware, and materials-handling experts with deep domain experience. The OSARO Partners Alliance convenes the right set of players to deliver success to both customers and partners. It fosters a community where participants can share knowledge, resources, and expertise to support their mutual clients as they evolve their supply-chain capabilities to keep e-commerce humming. ABOUT GEEK+ Geek+ is a global technology company leading the intelligent logistics revolution. We apply advanced robotics and AI technologies to realize flexible, reliable, and highly efficient solutions for warehouses and supply chain management. Geek+ is trusted by over 700 global industry leaders and has been recognized as the world leader in autonomous mobile robots. Founded in 2015, Geek+ has over 1,500 employees, with offices in the United States, Germany, the United Kingdom, Japan, South Korea, Mainland China, Hong Kong SAR, and Singapore. Visit geek+.com. ABOUT OSARO OSARO delivers best-in-class robotic piece-picking solutions for e-commerce where key challenges include high SKU inventories, complex packaging, and fragile items. In the rapidly evolving world of logistics technology, OSARO offers smarter automation, low-risk business plans, and its signature Hypercare support from concept exploration to onsite installation. OSARO’s intelligent robots enable goods-to-robot (G2R) use cases, where the greatest gains are yet to be made on the automated warehouse floor. Its machine-learning vision and control software provides the foundation for all its products. For more information, visit osaro.com.
- 05/18/2023
|
Top 5 Materials Stocks That May Explode In May - Amyris (NASDAQ:AMRS), MP Materials (NYSE:MP)
- The most oversold stocks in the materials sector presents an opportunity to buy into undervalued companies.
- 05/01/2023
|
5 Top Penny Stocks To Buy According To Analysts, Targets Up To 165%
- Analysts like these penny stocks but are they worth the risk?
- 04/28/2023
|
3 Biotech Stocks to Sell Before They're 6 Feet Under
- In a high-interest-rate environment, cash is king. All biotech companies will need to continue spending to finance their R&D.
- 04/24/2023
|
Amyris: Sub-Scale With High Fixed Costs And Limited Growth
- Amyris: Sub-Scale With High Fixed Costs And Limited Growth
- 04/19/2023
|
Amyris May be Oversold, but is it Worth Fighting the Shorts?
- Amyris, Inc. (NASDAQ: AMRS) is a small-cap company with a market cap of just over $381 million at the time of this writing. And the stock is a legitimate penny stock, with shares trading just over the $1 mark in early morning trading on April 17, 2023.
- 04/17/2023
|
Amyris (AMRS) and Givaudan Close Cosmetic Ingredients Deal
- Amyris (AMRS) and Givaudan collaborate to leverage the former's technological platform for designing, scaling and manufacturing the best-performing bio-fermented ingredients.
- 04/10/2023
|
Amyris (AMRS) Q4 Earnings and Revenues Lag Estimates
- Record revenues in the Consumer segment drive Amyris' (AMRS) top line in the fourth quarter.
- 03/17/2023
|
Amyris, Inc. (AMRS) Q4 2022 Earnings Call Transcript
- Amyris, Inc. (NASDAQ:AMRS ) Q4 2022 Earnings Conference Call March 15, 2023 4:30 PM ET Company Participants Han Kieftenbeld - Chief Financial Officer John Melo - President and Chief Executive Officer Eduardo Alvarez - Chief Operating Officer Conference Call Participants Colin Rusch - Oppenheimer Rachel Vatnsdal - JPMorgan Korinne Wolfmeyer - Piper Sandler Steven Mah - Cowen and Co. Sameer Joshi - H.C. Wainwright Laurence Alexander - Jefferies Operator Welcome to the Amyris Fourth Quarter 2022 Financial Results Conference Call.
- 03/16/2023
|
Amyris, Inc. (AMRS) Reports Q4 Loss, Misses Revenue Estimates
- Amyris, Inc. (AMRS) delivered earnings and revenue surprises of -160% and 27.18%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
- 03/15/2023
|
7 Penny Stocks To Watch Under $5 With Unusual Options Action
- Penny stocks with unusual options activity today. The post 7 Penny Stocks To Watch Under $5 With Unusual Options Action appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
- 03/14/2023
|
Penny Stocks To Buy? 7 To Watch Now After Big News
- Will penny stock news put these on your buy or sell list this week? The post Penny Stocks To Buy?
- 02/22/2023
|
The Next Big Disruptors? 3 Biotech Stocks Making Headlines.
- Since the biotech bonanza of the pandemic era, many biotech stocks have rocketed up and then down in price. Ginkgo Bioworks (NYSE: DNA ), Twist Bioscience (NASDAQ: TWST ), and Amyris (NASDAQ: AMRS ) all fell more than 75% from peak to trough, and may still have farther to fall.
- 02/17/2023
|
The 7 Best Stocks to Short This Week
- In order for a free market to operate, investors must be willing to participate in both sides of the transaction, which brings us to the topic of the stocks to short this week. If you're feeling optimistic about the pessimistic trajectory of embattled enterprises, this list may be for you.
- 02/13/2023
|
4 Penny Stocks To Watch This Week With High Short Interest
- Short Interest Stocks To Watch This Week Were you introduced to the
- 01/23/2023
|
Amyris: Darkest Before The Dawn
- Uncertainty still surrounds the strategic transaction, but it is still likely to close in the coming weeks. Amyris' cash flow problems are improving rapidly, but a large amount of outside cash will likely still be needed to reach profitability.
- 01/12/2023
|
3 Top Biotech Penny Stocks Under $3 To Watch Right Now
- Biotech penny stocks to watch right now. The post 3 Top Biotech Penny Stocks Under $3 To Watch Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
- 12/19/2022
|
3 Undervalued Penny Stocks According To Analysts
- Penny stocks to buy according to analysts. Are they right?
- 12/16/2022
|
Amyris: Show Us The Money
- Amyris is on the cusp of closing a record strategic transaction slated to generate ~$500mm in cash value. All indications point to a transaction closing in the next two to three weeks.
- 12/09/2022
|
10 Top Penny Stocks With Unusual Options Activity, Time To Buy?
- Penny stocks to watch with unusual options activity this week. The post 10 Top Penny Stocks With Unusual Options Activity, Time To Buy?
- 11/22/2022
|
7 Top Penny Stocks With Unusual Options Activity, Time To Buy?
- Penny stocks to watch with unusual options activity this week. The post 7 Top Penny Stocks With Unusual Options Activity, Time To Buy?
- 11/18/2022
|
Why Amyris Stock Was Driven Into the Ground on Wednesday
- To say that the company had a third quarter to forget is quite the understatement.
- 11/09/2022
|
Amyris, Inc. (AMRS) Reports Q3 Loss, Misses Revenue Estimates
- Amyris, Inc. (AMRS) delivered earnings and revenue surprises of -109.52% and 36.48%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
- 11/08/2022
|
Amyris, Inc. (AMRS) Q3 2022 Earnings Call Transcript
- Amyris, Inc. (NASDAQ:AMRS ) Q3 2022 Earnings Conference Call November 8, 2022 4:30 PM ET Company Participants Han Kieftenbeld - Chief Financial Officer John Melo - President & Chief Executive Officer Eduardo Alvarez - Chief Operating Officer Conference Call Participants Colin Rusch - Oppenheimer Rachel Vatnsdal - JPMorgan Korinne Wolfmeyer - Piper Sandler Steven Mah - Cowen and Company Dan Rizzo - Jefferies Rick Schottenfeld - Schottenfeld Opportunities Fund Graham Tanaka - Tanaka Capital Management Operator Welcome to the Amyris' Third Quarter 2022 Financial Results Conference Call. This call is being webcast live on the Events page of the Investors section of the Amyris website at amyris.com.
- 11/08/2022
|
From Spending Cash To Fermenting Money: Amyris Is Fit To Profit From High ROI Plants And Innovative Marketing
- "Fit To Win," high ROI Capex and innovative marketing are reducing cash burn equaling 19% of H2 2022 and 26% of 2023 product sales, delivering positive cash flow in 2023. Barra Bonita changes everything. Mfg. efficiencies and 30-60% lower COGS swings Amyris Ingredients margins from negative to positive 20-50%, producing faster and more profitable Ingredient growth than we expected.
- 11/07/2022
|
7 Cheap Penny Stocks to Buy Before They Pop Off
- It may seem a little crazy to talk about finding cheap penny stocks to buy at this time. The economy is cooling, and even blue-chip stocks are struggling to gain traction.
- 11/04/2022
|
Amyris: Consumer Business Cost Breakdown
- Supply chain problems appear to have caused elevated COGS and shipping and handling expenses, a problem faced by many beauty brands and DTC companies. Insourcing production and changing packaging will resolve some of these issues and help improve profitability.
- 11/01/2022
|
Why Amyris Stock Tumbled This Week
- A new loan facility caused some consternation.
- 10/14/2022
|
Penny Stocks To Buy Now: 3 To Watch With Unusual Options Activity Today
- Penny stocks with unusual options activity to watch today. The post Penny Stocks To Buy Now: 3 To Watch With Unusual Options Activity Today appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
- 10/04/2022
|
Recurring Marketing Exclusivity Deals Accelerate Amyris On Path To Profitability
- Amyris' more frequent and larger "exclusivity" deals introduce a unique, recurring catalyst to its business model that enhances profitability and requires raising our earnings estimates. We're raising our EPS estimates from ($1.19) to ($0.22)/share for 2022, from ($0.36) to ($0.09)/share for 2023, from $0.08 to $0.35/share for 2024 and from $0.62 to $0.88/share for 2025.
- 10/01/2022
|
Will Synthetic Biology Firm Amyris Post Net Income In 2024?
- Synthetic biology maker Amyris owns a 60% global market share for a product that's increasingly used in personal care products. Will it notch a profit in 2024?
- 09/26/2022
|
Wall Street Stock Market Today: Penny Stocks To Watch Before Fed Meeting
- What To Watch With 5 Hot Penny Stocks This Week The post Wall Street Stock Market Today: Penny Stocks To Watch Before Fed Meeting appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
- 09/19/2022
|
3 Stocks That Can Double Your Money According to Wall Street
- The experts say these stocks aren't getting half the appreciation that they deserve.
- 08/29/2022
|
Amyris, Inc. (AMRS) CEO John Melo on Q2 2022 Results - Earnings Call Transcript
- Amyris, Inc. (NASDAQ:AMRS ) Q2 2022 Earnings Conference Call August 9, 2022 9:00 AM ET Company Participants Han Kieftenbeld - Chief Financial Officer John Melo - President & Chief Executive Officer Eduardo Alvarez - Chief Operating Officer Conference Call Participants Colin Rusch - Oppenheimer Steven Mah - Cowen & Co. Sameer Joshi - H.C. Wainwright Rachel Vatnsdal - JPMorgan Randy Baron - Pinnacle Graham Tanaka - Tanaka Capital Management Operator Welcome to the Amyris Second Quarter 2022 Financial Results Conference Call.
- 08/09/2022
|
Amyris' Vertically-Integrated Business Model Transitioning From Investment Mode To Payoff Mode
- Amyris' disruptive vertically-integrated business model should deliver favorable results beginning in H2 2022, linking synthetic biology, clean chemistry, precision fermentation, scaling, & hero ingredients with consumers, partners, & retailers. After spending $2+ billion over 15+ years developing revolutionary science, Q3 startups of a next-generation fermentation facility and finishing plants should significantly boost Amyris profitability for Ingredients and Consumer Products.
- 08/08/2022
|
Amyris: Revenues Need To Catch Expenses
- There are high hopes that Amyris' Barra Bonita plant will rein in costs and improve the company's profitability. Fermentation is just one cost component though, meaning Barra Bonita will only have a limited impact, particularly on the consumer business.
- 07/08/2022
|
3 Short Squeeze Penny Stocks To Watch Before Next Week
- Short squeeze penny stocks to watch. The post 3 Short Squeeze Penny Stocks To Watch Before Next Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
- 06/24/2022
|
3 Tech Stocks at the Top of Our Watchlists
- This basket of infrastructure software, technical instrument, and specialty chemicals stocks looks like a good value.
- 06/24/2022
|
3 Stocks Wall Street Thinks Could Triple Your Money or Better
- Find out why the pros think these stocks could gain 200% or better.
- 05/31/2022
|
AMYRIS PARTICIPATES IN INVESTOR CONFERENCES ON MAY 23, 24 AND 25, 2022
- EMERYVILLE, Calif. , May 23, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform, today announced that management is participating in fireside chats at the following investor conferences this week: Morgan Stanley Sustainable Futures Conference, Monday, May 23 at 2:00 PM ET (virtual) Cowen 6th Annual Future of the Consumer Conference, Tuesday, May 24 at 10:40 AM ET (in-person) UBS Global Healthcare Conference, Wednesday, May 25 at 11:30 AM ET (in-person) Live webcasts of the presentations and replays will be available on the Investor Relations section of the company's website at https://investors.amyris.com/events-and-presentations.
- 05/23/2022
|
Better Buy: Gingko Bioworks vs. Amyris
- Which of these fallen stocks has the best chance of recovery?
- 05/22/2022
|
Amyris: A Question Of Agency Costs
- Amyris' cash burn is currently high and their balance sheet weak, placing them in a vulnerable position as sentiment deteriorates. The business continues to expand rapidly, but margin improvements have stalled as investments have increased and supply constraints have elevated costs.
- 05/16/2022
|
Amyris (AMRS) Earnings and Revenues Lag Estimates in Q1
- Amyris (AMRS) sees strong revenues in its consumer segment in Q1 driven by growth of its legacy brands and strong contribution from new brands.
- 05/12/2022
|
Amyris: Elevated Cash Usage Causes Investors To Head For The Exits
- Discussing sell-off in the shares after the company's Q1 report revealed a much higher cash usage than anticipated by market participants. Even when assuming cash usage to trend down for the remainder of the year, Amyris would likely run out of funds by the end of Q4 at the latest.
- 05/11/2022
|
Amyris, Inc. (AMRS) CEO John Melo on Q1 2022 Results - Earnings Call Transcript
- Amyris, Inc. (NASDAQ:AMRS ) Q1 2022 Results Conference Call May 10, 2022 9:00 AM ET Company Participants John Melo - President and Chief Executive Officer Han Kieftenbeld - Chief Financial Officer Conference Call Participants Colin Rusch - Oppenheimer Steven Mah - Cowen Sameer Joshi - H.C. Wainwright Laurence Alexander - Jefferies Michael Freeman - Raymond James Rachel Vatnsdal - JP Morgan Graham Tanaka - Tanaka Capital Management Operator Welcome to the Amyris' First Quarter 2022 Financial Results Conference Call.
- 05/10/2022
|
Amyris, Inc. (AMRS) Reports Q1 Loss, Misses Revenue Estimates
- Amyris, Inc. (AMRS) delivered earnings and revenue surprises of -54.17% and 11.83%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
- 05/10/2022
|
New Strong Sell Stocks for May 2nd
- ALEC, AMRS, and BLFS have been added to the Zacks Rank #5 (Strong Sell) List on May 2, 2022
- 05/02/2022
|
Amryis Update: Building Value One Brick At A Time
- 2022 is the year of the “Brick” for Amyris as it completes construction of the World's Largest Fermentation Plant, Consumer Production Facilities, and entry into global “Brick-and-Mortar” Retail Chain Stores. Amyris continues to achieve scale across Geographies, Retail Partners, Brands, and Product Lines.
- 04/28/2022
|
New Strong Sell Stocks for March 24th
- GHM, AMRS, and GDOT have been added to the Zacks Rank #5 (Strong Sell) List on March 24, 2022
- 03/24/2022
|
Will These Penny Stocks Explode in April? 3 to Watch This Week
- Which penny stocks are you watching in April? The post Will These Penny Stocks Explode in April?
- 03/20/2022
|
Amyris: JVN Could Be Their Most Valuable Brand Yet
- JVN Hair is a haircare brand that Amyris launched in 2021. The products are based around hemisqualane and the brand is fronted by Jonathan Van Ness.
- 03/19/2022
|
Amyris (AMRS) Q4 Earnings Lag Estimates, Sales Fall Y/Y
- Amyris (AMRS) sees strong revenues in its consumer segment in Q4 driven by the accelerated growth of its consumer brands.
- 03/04/2022
|
Amyris, Inc. (AMRS) CEO John Melo on Q4 2021 Results - Earnings Call Transcript
- Amyris, Inc. (AMRS) CEO John Melo on Q4 2021 Results - Earnings Call Transcript
- 03/01/2022
|
Amyris, Inc. (AMRS) Gains But Lags Market: What You Should Know
- Amyris, Inc. (AMRS) closed at $3.96 in the latest trading session, marking a +0.25% move from the prior day.
- 02/08/2022
|
Amyris: Surviving The Perfect Storm
- The Synthetic Biology sector underperformed the overall market in Q4 2021. Temporary supply chain disruptions drove the bulk of revenue headwinds.
- 02/03/2022
|
Amyris: MenoLabs Acquisition Extends The Platform Into New Markets
- The acquisition of MenoLabs extends Amyris' footprint into a new market.
- 01/28/2022
|
Amyris, Inc. (AMRS) Gains As Market Dips: What You Should Know
- In the latest trading session, Amyris, Inc. (AMRS) closed at $4.23, marking a +0.48% move from the previous day.
- 01/26/2022
|
4 Best Penny Stocks To Buy Now According To Top Wall Street Analysts
- 4 penny stocks to buy right now according to top Wall Street analysts. The post 4 Best Penny Stocks To Buy Now According To Top Wall Street Analysts appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
- 01/24/2022
|
Amyris: Success With RebM Will Indicate A Manufacturing Advantage
- RebM is an alternative sweetener and one of Amyris' first forays into the food and beverage market. In addition to ingredient sales, Amyris has a consumer brand (Purecane) based on their RebM product.
- 01/19/2022
|
Amyris, Inc. (AMRS) Flat As Market Gains: What You Should Know
- Amyris, Inc. (AMRS) closed at $4.99 in the latest trading session, marking no change from the prior day.
- 01/14/2022
|
Amyris, Inc. (AMRS) Gains As Market Dips: What You Should Know
- Amyris, Inc. (AMRS) closed the most recent trading day at $4.59, moving +1.1% from the previous trading session.
- 01/07/2022
|
Amyris, ImmunityBio Shares Trading Higher On COVID-19 Vaccine Joint Venture
- Amyris Inc (NASDAQ: AMRS) and ImmunityBio (NASDAQ: IBRX) have completed their previously announced joint venture agreement to accelerate the commercialization of a next-generation COVID-19 vaccine. Upon completion of human trials and regulatory approval, the joint venture's goal is to start delivering the second-generation vaccine in 2022 as soon as it is practically possible to deliver.
- 01/03/2022
|
Amyris: Enabling Environmentally Sustainable Beauty Products
- Amyris: Enabling Environmentally Sustainable Beauty Products
- 01/02/2022
|
Are Options Traders Betting on a Big Move in Amyris (AMRS) Stock?
- Investors need to pay close attention to Amyris (AMRS) stock based on the movements in the options market lately.
- 12/20/2021
|
The 7 Best Green Energy Stocks to Grow Your Portfolio in 2022
- Green Energy stocks look to be coming back into vogue in 2022 making these seven plays attractive for the longer term. The post The 7 Best Green Energy Stocks to Grow Your Portfolio in 2022 appeared first on InvestorPlace.
- 12/20/2021
|
BIGZ: Innovation Goes Into Meltdown
- BIGZ: Innovation Goes Into Meltdown
- 12/19/2021
|
3 Beaten-Down Growth Stocks to Buy for 2022
- After falling by at least a third over the past month, these former highfliers are poised to reach new heights in the new year.
- 12/18/2021
|
Amyris: Well Positioned In The Cannabinoids Market
- Amyris is the only synthetic biology company developing and manufacturing a portfolio of products at scale. Biosynthesis of cannabinoids reduces regulatory concerns and makes minor cannabinoids commercially viable.
- 12/17/2021
|
3 Growth Stocks to Fuel Your 2022 Financial Freedom
- This basket of industrial and electric vehicle stocks is primed to pole vault your portfolio.
- 12/12/2021
|
Amyris: Vaccine Upside
- Amyris is the only synthetic biology company developing and manufacturing a portfolio of products at scale. Amyris has obtained access to differentiated vaccine technology through a licensing arrangement with the Infectious Disease Research Institute.
- 11/30/2021
|
Amyris Buying Opportunity Created By Q3 Miss, Mega Convert And Potential Revolutionary COVID Vaccine
- Big Revenue miss for Q3 due to supply chain shortages and Amyris guides lower for Q4. Surprise $690 million convert is less dilutive (12%, not 18%) and at a beneficially higher effective conversion price ($15.90, not $10.75/share) due to a capped call hedge.
- 11/19/2021
|
Amyris: Valuations Are Attractive After Hype Around Synthetic Biotech Is Quelled By CEO's Ambitious Guidance
- Amyris' synthetic biotechnology breakthrough with squalene. The real crown jewel of Amyris' current business segment.
- 11/15/2021
|
Why Shares of Amyris Are Plummeting This Week
- There's nothing artificial about the plunging price of this synthetic biology stock.
- 11/11/2021
|
Why Shares of Amyris Are Getting Crushed Today
- Bears are turning their backs on this synbio stock today.
- 11/09/2021
|
Amyris (AMRS) Stock: Why The Price Substantially Fell Today
- The stock price of Amyris Inc (NASDAQ: AMRS) fell over 30% during intraday trading today. This is why it happened.
- 11/09/2021
|
Amyris, Inc. (AMRS) CEO John Melo on Q3 2021 Results - Earnings Call Transcript
- Amyris, Inc. (AMRS) CEO John Melo on Q3 2021 Results - Earnings Call Transcript
- 11/08/2021
|
Amyris, ImmunityBio Join Forces For Next-Gen COVID-19 RNA Vaccine
- Amyris Inc (NASDAQ: AMRS) has entered into a 50:50 joint venture arrangement with ImmunityBio Inc (NASDAQ: IBRX) to commercialize a next-gen COVID-19 vaccine. The parties have signed a binding term sheet, and a definitive agreement is in process and is expected to be executed within the next month.
- 11/08/2021
|
Amyris: Assessing Financial Capacity To Sustain Organic Growth, Carry COVID Research And Pay For Acquisition
- Amyris: Assessing Financial Capacity To Sustain Organic Growth, Carry COVID Research And Pay For Acquisition
- 11/04/2021
|
3 Genomics Stocks That Could Soar 60% or Better, According to Wall Street
- The genomic revolution is upon us and these stocks could be great vehicles for investors who want to take advantage of it.
- 10/27/2021
|
3 Great Stocks You Can Buy With $50 Right Now
- You can pick up small pieces of these great businesses for next to nothing.
- 10/20/2021
|
7 Sin Stocks to Buy as the World Goes to Hell in a Handbasket
- Sin stocks are considered defensive and tend to remain more stable under tough economic conditions. Here are the top ones to watch in 2021.
- 10/04/2021
|
Amyris To Host Fourth Webinar In Its Virtual Investor Mini-Series
- EMERYVILLE, Calif., Sept. 22, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in the Clean Health, Beauty and Wellness markets, today announced that it will host its fourth virtual investor webinar on Tuesday, September 28, 2021.
- 09/22/2021
|
Amyris And Jonathan Van Ness Launch JVN Hair A Transformation In Clean Hair Products
- EMERYVILLE, Calif., Aug. 26, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced the launch of JVN™, a clean hair products brand.
- 08/26/2021
|
Amyris Among Today's Top Shorts Amid News That The Central Bank Could Taper Its Bond Purchasing Program
- The Dow Jones is up 150 points, or nearly 0.5%, and the S&P 500 and Nasdaq are each up about 0.5%. Make the most of this market with today's best short plays from Q.ai's deep learning algorithms.
- 08/23/2021
|
Amyris: Leading The ESG Investing Push
- Amryris will lead the ESG growth space for years to come. Amyris is providing a sustainable growth solution that will continue to be impactful.
- 08/20/2021
|
Why Amyris Stock Jumped Today
- The company announced promising results from a study of its experimental intranasal COVID-19 vaccine.
- 08/20/2021
|
Amyris Achieves Promising In-Vivo Results For Intranasal Delivery Of RNA/NLC Vaccine
- EMERYVILLE, Calif., Aug. 20, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced promising in-vivo results in a study of its licensed RNA vaccine through intranasal delivery, developed in collaboration with the Infectious Disease Research Institute (IDRI).
- 08/20/2021
|
Amyris Inc Among Today's Top Shorts As Major Indices Fall Following The Fed's Meeting Minutes
- The Dow Jones dropped around 145 points or 0.4%, the S&P 500 fell 0.4%, and the Nasdaq dipped 0.5%. Find opportunities in today's market with today's best short plays from Q.ai's artificial intelligence.
- 08/19/2021
|
Amyris Launches Terasana Clinical Clean Skincare Brand
- EMERYVILLE, Calif., Aug. 19, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced the launch of Terasana™ Clinical, a clean skincare brand.
- 08/19/2021
|
AI Identifies Amyris Inc Among Today's Top Shorts As Investors Anticipate The Fed's Next Stimulus Moves
- The 10-year Treasury yield inched up to around 1.27%, the Dow fell 120 points, the S&P 500 dipped about 0.2%, and the Nasdaq stayed nearly flat. If you're looking for a way to play this market, the deep learning algorithms at Q.ai have crunched the data to offer up today's Top Shorts.
- 08/18/2021
|
Arvinas Inc Ranked Among Today's Top Shorts
- Markets were slightly lower this morning after the Dow Jones touched all-time highs at the open. Find opportunities in today's market with the best short plays from Q.ai's deep learning algorithms.
- 08/12/2021
|
EcoSynthetix Hits Key Milestones With Its Disruptive Biopolymers
- EcoSynthetix Hits Key Milestones With Its Disruptive Biopolymers
- 08/11/2021
|
Arvinas Inc Ranked Among Today's Top Shorts
- The Dow Jones rose 10 points, while both the S&P 500 and Nasdaq also saw mild gains. Find opportunities in today's market with the best short plays from Q.ai's deep learning algorithms.
- 08/10/2021
|
Zymergen's Implosion Makes Amyris a Screaming Buy
- The flashy synthetic-biology start-up ran into a wall that Amyris has already learned how to climb over.
- 08/09/2021
|
Amyris Inc Ranked Among Today's Top Shorts
- To close out August's opening week, the Dow Jones rose 101 points, or 0.3%, the S&P 500 was flat, and the Nasdaq fell 0.4%. Find opportunities in today's market with the best short plays from Q.ai's deep learning algorithms.
- 08/06/2021
|
Amyris, Inc. Reports Second Quarter 2021 Financial Results
- EMERYVILLE, Calif., Aug. 5, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health, Beauty and Wellness markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced financial results for its second quarter ended June 30, 2021.
- 08/05/2021
|
AI Identifies Amyris Inc Among Today's Top Shorts
- The Dow Jones fell about 163 points, the S&P 500 dipped 0.4%, and the Nasdaq inched up just a bit. Find opportunities in today's market with the best short plays from Q.ai's deep learning algorithms.
- 08/04/2021
|
3 High-Growth Healthcare Stocks to Buy in August
- These potential stock rockets are well worth the different risks they present.
- 08/03/2021
|
Will Amyris, Inc. (AMRS) Report Negative Earnings Next Week? What You Should Know
- Amyris, Inc. (AMRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 07/29/2021
|
Amyris Stock Forecast For 2021: Where Is It Headed?
- Amyris develops bio-based renewable alternatives to petrochemical and animal-based ingredients with a wide range of applications. The company is generating strong growth across a growing consumer brands business along with several licensing deals.
- 07/28/2021
|
Amyris Inc Ranked Among Today's Top Shorts
- The indices are on pace to end the week in the green, backed by a 4-day winning streak. Make the most of this market with today's best short plays from Q.ai's deep learning algorithms.
- 07/23/2021
|
Amyris To Host Second Quarter 2021 Financial Results Conference Call On August 5
- EMERYVILLE, Calif., July 21, 2021 /PRNewswire/ -- Amyris, Inc., (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health, Beauty and Wellness markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that it will issue its financial results for the second quarter ended June 30, 2021 on the morning of Thursday, August 5, 2021, prior to the opening of the financial markets.
- 07/21/2021
|
AMRS Stock: Why Biotech Stock Amyris Is Shooting Higher Today
- Shares of AMRS stock are on the move today as retail investors appear to be intrigued by this name, providing buying momentum. The post AMRS Stock: Why Biotech Stock Amyris Is Shooting Higher Today appeared first on InvestorPlace.
- 07/19/2021
|
Fluor Corp Ranked Among Today's Top Shorts
- Markets started off the week right where they left off on Friday, with a sharp pullback at the open. Find opportunities with today's best short plays from Q.ai's artificial intelligence.
- 07/19/2021
|
AI Identifies Amyris Inc Among Today's Top Shorts
- Thursday marked a lower day on Wall Street with all three indices trading in the red, albeit slightly. Find opportunities in today's market with the best short plays from Q.ai's deep learning algorithms.
- 07/15/2021
|
Amyris Publishes Environmental, Social and Governance (ESG) Report and Sets ESG Impact Goals
- EMERYVILLE, Calif., July 13, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health, Beauty and Wellness markets through its consumer brands and a top supplier of sustainable and natural ingredients, today released its first Environmental, Social and Governance (ESG) report, underscoring the company's founding commitment to making people and the planet healthier.
- 07/13/2021
|
AI Identifies Amyris Inc Among Today's Top Shorts
- Monday markets were slow today, trading flat, as investors eyed the start of Q2 earnings season. Find opportunities with today's Top Shorts from Q.ai's deep learning algorithms.
- 07/12/2021
|
3 Top Life Science Stocks to Buy on Sale Right Now
- Shares of these overlooked gems could make investors very rich once the rest of the market notices their value.
- 07/11/2021
|
Carvana Co Ranked Among Today's Top Shorts
- Markets were well in the red this morning with the S&P off about 1.2%, the Dow lower by about 1%, and the Nasdaq taking the brunt of selling pressure down just under 1.5%. Find opportunities in today's market with the best short plays.
- 07/08/2021
|
Fluor Corp Ranked Among Today's Top Shorts
- The S&P 500 moved higher this morning, led by tech stocks, as the Nasdaq aimed for another record open. Find opportunities in today's market with the best short plays from Q.ai's deep learning algorithms.
- 07/07/2021
|
Amyris Completes First Major License For Leading RNA Vaccine Advancing Technology To Human Trials
- EMERYVILLE, Calif., July 1, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced that it has signed an exclusive license with Nant Africa, LLC relating to the development and use of the RNA COVID vaccine Amyris developed in coordination with the Infectious Disease Research Institute (IDRI).
- 07/01/2021
|
Amyris: How Lead In Synthetic Biology Could Brew Up Big Profits
- Amyris: How Lead In Synthetic Biology Could Brew Up Big Profits
- 06/28/2021
|
Breaking Down a Wild Week in the World of Weed Stocks
- Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week and look ahead to how the cannabis industry continues to take shape in 2021.
- 06/18/2021
|
Amyris to Present at the Jefferies Virtual Consumer Conference on June 23, 2021
- EMERYVILLE, Calif., June 16, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, today announced that John Melo, President and Chief Executive Officer, will participate at the Jefferies Virtual Consumer Conference on Wednesday, June 23 rd at 3:15 pm ET.
- 06/16/2021
|
Finding Value In Beauty And Wellness Through Amyris
- Amyris is a bio-manufacturer, producing alternative ingredients to be used in the production of beauty and wellness products, in addition to producing consumer goods. The company exhibits 47% growth in product revenues, has reduced debts, and its cash position has improved.
- 06/06/2021
|
Amyris to Present at the Virtual Morgan Stanley 6th Annual Sustainable Futures Conference on June 9, 2021
- EMERYVILLE, Calif., June 2, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, today announced that John Melo, Director, President and Chief Executive Officer, will participate in a virtual fireside chat at the Morgan Stanley 6th Annual Sustainable Futures Conference on Wednesday, June 9 th at 3:30 pm ET.
- 06/02/2021
|
Amyris Inc And Blink Charging Co Among Today's Top Shorts
- Jobless claims fell to yet another pandemic-era low, and cyclical stocks popped while the rotation out of tech continued for another day. Meanwhile, Q.ai's Artificial Intelligence systems have assessed each firm to find the best short plays.
- 05/27/2021
|
Amyris Inc Among Today's Top Shorts As The Dow, S&P 500, And Nasdaq All Climb
- The Dow Jones rose 70 points, the S&P 500 gained 0.3%, and the Nasdaq climbed 0.6%. Meanwhile, Q.ai's artificial intelligence has assessed each firm to find the best short plays of the day.
- 05/25/2021
|
BIGZ: Holdings Updated - Great Diversifier Into Growth Names
- BIGZ launched late in March, they have finally updated their holdings to include the top ten.
- 05/24/2021
|
Amyris Inc And Carvana Co Among Today's Top Shorts
- Although stocks were deeply in the red in overnight trading, the jobless claims can be credited for the sharp reversal today. Q.ai's artificial intelligence systems assessed each firm to find the best short plays.
- 05/20/2021
|
AI Model Rates Redfin And Carvana Top Short Today
- Going into today, the Dow Jones continued its sell-off and fell more than 150 points while the S&P 500 lost 0.6% and the Nasdaq dipped more than 1%. Our AI has identified the following stocks rated Top Short today.
- 05/12/2021
|
Amyris, Inc. (AMRS) CEO John Melo on Q1 2021 Results - Earnings Call Transcript
- Amyris, Inc. (AMRS) CEO John Melo on Q1 2021 Results - Earnings Call Transcript
- 05/06/2021
|
Amyris, Inc. (AMRS) Reports Q1 Loss, Tops Revenue Estimates
- Amyris, Inc. (AMRS) delivered earnings and revenue surprises of -575.00% and 367.23%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
- 05/06/2021
|
Amyris (AMRS) to Report Q1 Earnings: What's in the Offing?
- Amyris' (AMRS) Q1 results are likely to have benefited from continued strong growth in its consumer brands.
- 05/05/2021
|
Amyris And Ingredion Partner To Manufacture And Market Sugar Reduction And Fermentation-based Food Ingredients
- EMERYVILLE, Calif. and WESTCHESTER, Ill.
- 05/03/2021
|
Amyris, Inc. (AMRS) Dips More Than Broader Markets: What You Should Know
- Amyris, Inc. (AMRS) closed at $14.56 in the latest trading session, marking a -1.42% move from the prior day.
- 04/30/2021
|
Amyris Hosts Successful Final Session Of Its Three-Part Virtual Mini-Series
- EMERYVILLE, Calif., April 26, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, successfully hosted the third webinar in its virtual investor mini-series themed "Delivering on the Promise of Synthetic Biology.
- 04/26/2021
|
Amyris To Host First Quarter 2021 Financial Results Conference Call On May 6
- EMERYVILLE, Calif., April 21, 2021 /PRNewswire/ -- Amyris, Inc., (Nasdaq: AMRS) a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced that it will issue its financial results for the first quarter ended March 31, 2021 on Thursday, May 6, 2021 prior to the opening of the financial markets.
- 04/21/2021
|
Amyris To Acquire EcoFabulous Clean Beauty Brand Focused On Fast-Growing Gen Z Consumer Segment
- EMERYVILLE, Calif., April 15, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that it has executed a binding term sheet for the acquisition of Gen Z-focused beauty brand, EcoFabulous Cosmetics (EcoFabulous).
- 04/15/2021
|
Unpacking This Sustainable Biotech Stock Breakout
- Amyris, Inc. (NASDAQ:AMRS) is a synthetic biotech and renewable chemical company.
- 04/09/2021
|
Amyris Announces Pricing of a $300.0 Million Public Offering (Secondary and Primary) of Common Stock
- EMERYVILLE, Calif., April 9, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS) ("Amyris"), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced the pricing of an underwritten public offering of an aggregate of 19,047,619 shares of its common stock at a public offering price of $15.75 per share, which consists of a secondary offering of 11,390,797 shares to be sold, in the aggregate, by DSM International B.V.
- 04/09/2021
|
Amyris Announces Proposed Public Offering (Secondary And Primary) Of Common Stock
- EMERYVILLE, Calif., April 7, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS) ("Amyris"), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced the commencement of a proposed underwritten public offering of shares of its common stock.
- 04/07/2021
|
Amyris: A Mid-Cap That May Become a Significant Disruptor
- If you check the summary page for Amyris Inc. (NASDAQ:AMRS) at GuruFocus, you'll find a lot of weak metrics. That includes ratings of 1 out of 10 for both financial strength and profitability.
- 04/06/2021
|
8 High-Risk Stocks to Buy That Are Worth Taking A Chance On
- A rebounding economy is a good time to thaw out your risk capital and start buying some high-risk stocks with long-term potential. The post 8 High-Risk Stocks to Buy That Are Worth Taking A Chance On appeared first on InvestorPlace.
- 04/06/2021
|
Amyris to Present at Cowen's 2nd Annual Consumer Platforms for the Next Generation Summit on April 6, 2021
- EMERYVILLE, Calif., April 5, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that management will participate in a fireside chat at Cowen's 2nd Annual Consumer Platforms for the Next Generation Summit on Tuesday, April 6 th at 9:30 am ET.
- 04/05/2021
|
Amyris To Host Third Webinar In Its Virtual Investor Mini-Series
- EMERYVILLE, Calif., April 1, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that it will host the third webinar in its virtual investor mini-series themed "Delivering on the Promise of Synthetic Biology.
- 04/01/2021
|
Amyris Is Strengthening Its Lead In The Next Industrial Revolution
- Just as Intel advanced the Digital Revolution and Tesla the EV Revolution, Amyris can drive the Synthetic Biology Revolution to replace high margin segments of the $5.7 Trillion chemical industry.
- 03/31/2021
|
Amyris Delivers Record Production Of CBG For Consumer Skincare Formulations
- EMERYVILLE, Calif., March 25, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, announced today the achievement of another breakthrough with its production of Cannabigerol (CBG) from fermentation for consumer skincare treatment formulations.
- 03/25/2021
|
Top Wall Street analysts are unanimously bullish on these stocks
- TipRanks analyst ranking service pinpoints Wall Street's best-performing stocks, like Amazon and Microsoft
- 03/21/2021
|
Synthetic Biology Company Amyris Swapped Biofuels For Personal Care, Its Stock Is Up 10-Fold Over The Past Year
- The market for sustainable personal care products is booming. Amyris, one of the earliest synthetic biology companies, is launching new brands to ride the wave.
- 03/15/2021
|
The 'Boiler Room' Stock Pitch Recap: Nautilus, Uber, Lamar Advertising And More
- Every Friday, at 3 p.m. ET, Ritholtz Wealth Management CEO Josh Brown and Benzinga CEO Jason Raznick host "The Boiler Room," a Clubhouse audio chat where listeners can pitch their favorite stock.
- 03/13/2021
|
AMRS Stock Price Increased 27.39%: Why It Happened
- The stock price of Amyris Inc (NASDAQ: AMRS) has increased by 27.39%. This is why it happened.
- 03/03/2021
|
Amyris, Inc. (AMRS) CEO John Melo on Q4 2020 Results - Earnings Call Transcript
- Amyris, Inc. (AMRS) CEO John Melo on Q4 2020 Results - Earnings Call Transcript
- 03/02/2021
|
Amyris Hasn't Even Begun To Peak
- Amyris is up over 400% over the past three months. Amyris still offers tremendous upside value to be had when compared to its peers on P/S.
- 03/01/2021
|
Top Marijuana Stocks on the NASDAQ for March 2021
- These are the marijuana stocks on the NASDAQ with the best value, fastest growth, and the most momentum for March.
- 02/26/2021
|
Amyris Changes The Cannabis Game And Hits New 52 Week High
- Amyris' stock price has been on a serious uptrend increasing 636% in three months. The company has innovated a method to synthesize cannabinoids in yeast.
- 02/10/2021
|
Top Marijuana Stocks for February 2021
- These are the marijuana stocks with the best value, fastest growth, and most momentum for February 2021.
- 01/26/2021
|
7 Great Cheap Stocks To Buy For Solid Growth In 2021
- Some of the best cheap stocks for 2021 include chipmakers like UMC stock and pharmaceuticals in the COVID-19 vaccine race such as INO stock. The post 7 Great Cheap Stocks To Buy For Solid Growth In 2021 appeared first on InvestorPlace.
- 01/26/2021
|
Top Marijuana Stocks on the NASDAQ for February 2021
- These are the marijuana stocks on the NASDAQ with the best value, fastest growth, and the most momentum for February.
- 01/21/2021
|
Citigroup, Goldman Sachs, JPMorgan, Tesla and More Wednesday Afternoon Analyst Calls
- Over halfway through the trading day on Wednesday, and the broad markets are making a run into the afternoon.
- 01/06/2021
|
7 Penny Stocks on a Tear Right Now and Still Worth Buying
- Looking for penny stocks to buy? Click for seven that are hot right now and should continue to rise in the future.
- 12/29/2020
|
Amyris Announces Bonsucro Certification Sustainable Sugarcane Production For Clean Ingredients
- EMERYVILLE, Calif., Dec. 28, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced that it has...
- 12/28/2020
|
Are Options Traders Betting on a Big Move in Amyris (AMRS) Stock?
- Investors need to pay close attention to Amyris (AMRS) stock based on the movements in the options market lately.
- 12/24/2020
|
Top Marijuana Stocks on the NASDAQ for January 2021
- These are the marijuana stocks on the NASDAQ with the best value, fastest growth, and the most momentum for January.
- 12/23/2020
|
Amyris (AMRS) Surges: Stock Moves 7.1% Higher
- Amyris (AMRS) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.
- 12/21/2020
|
Amyris Is Setting Up For A Monster Run
- Amyris has multiple major transactions around the corner. The political and market environment favor the company greatly.
- 12/17/2020
|
Amyris, Inc. (AMRS) CEO John Melo on Q3 2020 Results - Earnings Call Transcript
- Amyris, Inc. (AMRS) CEO John Melo on Q3 2020 Results - Earnings Call Transcript
- 11/05/2020
|
Amyris And Rosie Huntington-Whiteley Announce Creation Of New Clean Beauty Brand And Business Partnership
- EMERYVILLE, Calif., Oct. 30, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, and Rosie Huntington-Whiteley, model turned...
- 10/30/2020
|
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Amyris, Inc. (AMRS) on Behalf of Investors
- BENSALEM, Pa.--(BUSINESS WIRE)---- $AMRS #CLASSACTION--INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Amyris, Inc. (AMRS) on Behalf of Investors
- 10/26/2020
|
Global Sustainable Aviation Fuel Market (2020 to 2030) - Rising Demand for SAF by Airlines Presents Opportunities - ResearchAndMarkets.com
|
Amyris (NASDAQ:AMRS) Stock Price Down 6.9%
- Amyris, Inc. (NASDAQ:AMRS) fell 6.9% during trading on Friday . The stock traded as low as $2.82 and last traded at $2.82. 1,523,948 shares traded hands during mid-day trading, a decline of 37% from the average session volume of 2,420,260 shares. The stock had previously closed at $3.03. Several research firms have recently commented on […]
- 10/18/2020
|
The Law Offices of Frank R. Cruz Announces Investigation of Amyris, Inc. (AMRS) on Behalf of Investors
- The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors of Amyris, Inc (“Amyris” or the “Company”) (NASDAQ:
- 10/08/2020
|
Why Amyris Fell 11% in September | The Motley Fool
- It could have been a lot worse.
- 10/07/2020
|
R&D Surprises Offer Amyris Unbounded Upside (NASDAQ:AMRS)
- Amyris' engineered yeast strains and advanced fermentation can produce an unlimited number of new products for billion-dollar markets.
- 09/30/2020
|
Amyris On Track For Cash Flow, Earnings And 70%/Year Returns (NASDAQ:AMRS)
- Amyris bolsters balance sheet, shifting focus to cash flow, 40-50% revenue growth and earnings (we estimate $0.72 EPS in 2024).
- 09/29/2020
|
Amyris Inc (NASDAQ:AMRS) Shares Purchased by American International Group Inc.
- American International Group Inc. increased its stake in shares of Amyris Inc (NASDAQ:AMRS) by 21.6% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 42,942 shares of the biotechnology company’s stock after acquiring an additional 7,623 shares during the period. […]
- 09/24/2020
|
Amyris Patent Lawsuit, And Other News: The Good, Bad And Ugly Of Biopharma (NASDAQ:AMRS)
- Amyris Inc. suffers a setback over patent lawsuit.
- 09/17/2020
|
Why Amyris Shares Dropped 26% Today | The Motley Fool
- The company has responded to a $881 million lawsuit brought against it yesterday.
- 09/11/2020
|
Mid-Afternoon Market Update: Nasdaq Drops Over 100 Points; A-Mark Precious Metals Shares Spike Higher
- Toward the end of trading Friday, the Dow traded up 0.26% to 27607.31 while the NASDAQ fell 1.05% to 10805.00. The S&P also fell, dropping 0.24% to 3331.34.
The U.S. has the...
- 09/11/2020
|
Oppenheimer: These 3 Penny Stocks Have Triple-Digit Upside Potential
- These penny stocks are company names that won’t break the bank, and boast colossal growth prospects for the 12 months ahead.
- 09/10/2020
|
Amyris: Avoid The Shares Until Key Cannabinoid Collaboration Issues And Capital Requirements Have Been Addressed
- Discussing key takeaways from the company's Q2/2020 earnings report. Management reiterated aggressive top- and bottom-line projections.
- 08/19/2020
|
Amyris Appoints Sheila Shekar Pollak As Chief Marketing Officer Of Biossance
- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced the appointment of Sheila Shekar Pollak as Chief Marketing Officer of its Biossance™ Clean Beauty skincare brand. Sheila has a proven track record in developing and executing world-class brand and marketing strategies that deliver high growth consumer brands.
- 08/14/2020
|
Amyris Reports Its Largest First-Half Operating Loss Since 2012 | The Motley Fool
- A growing balance of deferred cost of product revenue suggests business fundamentals might be significantly worse than reported.
- 08/07/2020
|
Amyris, Inc. Reports Second Quarter 2020 Results
- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced financial results for its second quarter ended June 30, 2020.
- 08/06/2020
|
Brokerages Expect Amyris Inc (NASDAQ:AMRS) Will Announce Earnings of -$0.19 Per Share
- Equities research analysts expect that Amyris Inc (NASDAQ:AMRS) will report ($0.19) earnings per share (EPS) for the current quarter, Zacks reports. Two analysts have issued estimates for Amyris’ earnings. The highest EPS estimate is ($0.18) and the lowest is ($0.20). Amyris reported earnings of ($0.76) per share during the same quarter last year, which would […]
- 08/04/2020
|
Top Marijuana Stocks for August 2020
- The marijuana industry is made up of companies that either support or are engaged in the research, development, distribution, and sale of medical and recreational marijuana. Many big marijuana companies have continued to post sizable net losses as they focus on investing in equipment to speed up revenue growth, which remains strong despite the pandemic-spurred economic downturn. Marijuana stocks, as represented by the ETFMG Alternative Harvest ETF (MJ), have dramatically underperformed the broader market over the past 12 months.
- 07/30/2020
|
Rigrodsky & Long, P.A. Files Class Action Suit Against Amyris, Inc.
- WILMINGTON, Del., July 29, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it has filed a class action complaint in the United States District Court for the District of Delaware on behalf of holders of Amyris, Inc. (“Amyris” or the “Company”) (NASDAQ GS: AMRS) common stock (the “Complaint”). The Complaint, which alleges violations of the Securities Exchange Act of 1934 against Amyris and its Board of Directors (the “Board”), is captioned Sabatini v. Amyris, Inc., Case No. 1:20-cv-01013 (D. Del.). If you wish to discuss this action or have any questions regarding this notice or your rights, please contact plaintiff’s counsel, Seth D. Rigrodsky or Gina M. Serra, toll free at (888) 969-4242, by e-mail at info@rl-legal.com, or at https://www.rigrodskylong.com/offices-contact.On July 6, 2020, Amyris filed a proxy statement (the “Proxy Statement”) with the United States Securities and Exchange Commission. The Proxy Statement scheduled a special meeting of Amyris’ stockholders to vote upon the approval of: (i) the issuance of shares of Amyris’ common stock issuable upon exercise by Foris Ventures, LLC of its option to convert all or any portion of the secured indebtedness outstanding under the Amended and Restated Loan and Security Agreement dated October 28, 2019, as further amended on June 1, 2020, into shares of the Company’s common stock; and (ii) the issuance of shares of Amyris common stock issuable upon the conversion of the Company’s Series E Convertible Preferred Stock. Among other things, the Complaint alleges that defendants issued materially incomplete disclosures in the Proxy Statement. If you wish to serve as lead plaintiff, you must move the Court no later than September 28, 2020. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Any member of the proposed class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member.Rigrodsky & Long, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.Attorney advertising. Prior results do not guarantee a similar outcome.CONTACT:Rigrodsky & Long, P.A. Seth D. Rigrodsky Gina M. Serra (888) 969-4242 (Toll Free) (302) 295-5310 Fax: (302) 654-7530 info@rl-legal.com https://rl-legal.com
- 07/29/2020
|
INVESTOR ALERT: Monteverde & Associates PC Announces an Investigation of Amyris, Inc. - AMRS
- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating Amyris, Inc. ("Amyris" or the "Company") (Nasdaq: AMRS) relating to the Company's June 1 and June 4, 2020 financing transactions, which permit Foris Ventures, LLC to obtain Amyris common stock. Under the terms of the transaction, Amyris shareholders would receive $3.00 for each share of Amyris common stock owned.
- 07/29/2020
|
SHAREHOLDER ALERT: WeissLaw LLP Investigates Amyris, Inc.
- URGENT: SHAREHOLDER VOTE AUGUST 14, 2020
- 07/29/2020
|
Here's Why Amyris Stock Rose as Much as 12.2% Today | The Motley Fool
- The synthetic biology pioneer announced a collaboration for its vaccine adjuvant ambitions.
- 07/27/2020
|
Amyris and The Infectious Disease Research Institute Partner to Advance Novel RNA Vaccine Platform Beginning With COVID-19 Application
- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets and IDRI (Infectious Disease Research Institute) today announce the signing of a binding term sheet for a planned COVID-19 RNA (ribonucleic acid) vaccine technology program. The program combines IDRI's expertise in combating infectious diseases with Amyris' fermentation platform technology, with the goal to create semi-synthetic squalene-based adjuvants at scale. IDRI's RNA vaccine platform is expected to offer significant differentiated advantages over other RNA vaccines currently in development and will be further enhanced by a scalable Amyris adjuvant.
- 07/27/2020
|
Amyris To Host Second Quarter 2020 Financial Results Conference Call On August 6
- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that the company will host a conference call for investors and analysts on Thursday, August 6, 2020 at 6:00 a.m. PT (9:00 a.m. ET) to discuss its second quarter 2020 results.
- 07/23/2020
|
9 Lesser-Known Marijuana Stocks to Consider Post-Pandemic
- Strangely enough, the awful coronavirus pandemic that hurt smaller marijuana stocks could be the catalyst for a sizable recovery.
- 07/22/2020
|
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Amyris, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
- INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Amyris, Inc.
- 07/20/2020
|
IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Amyris, Inc. and Encourages Investors with Losses to Contact the Firm
- LOS ANGELES, CA / ACCESSWIRE / July 20, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Amyris, Inc.
- 07/20/2020
|
INVESTIGATION ALERT: Labaton Sucharow is Investigating Amyris, Inc. for Potential Securities Violations and Breach of Fiduciary Duty (NASDAQ:AMRS)
- WILMINGTON, DE / ACCESSWIRE / July 20, 2020 / Labaton Sucharow, a nationally ranked shareholder rights firm, is investigating potential securities violations and breach of fiduciary duty claims against biotechnology company Amyris, Inc.
- 07/20/2020
|
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Amyris, Inc. and Encourages Investors with Losses to Contact the Firm
|
ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Amyris, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
- LOS ANGELES, CA / ACCESSWIRE / July 16, 2020 / The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Amyris, Inc. ("Amyris" ...
- 07/16/2020
|
INVESTIGATION ALERT: The Schall Law Firm Announces It Is Investigating Claims Against Amyris, Inc. and Encourages Investors With Losses in Excess of $100,000 to Contact the Firm
- INVESTIGATION ALERT: The Schall Law Firm Announces It is Investigating Claims Against Amyris, Inc.
- 07/16/2020
|
INVESTIGATION ALERT: The Schall Law Firm Announces It Is Investigating Claims Against Amyris, Inc. and Encourages Investors With Losses in Excess of $100,000 to Contact the Firm
- INVESTIGATION ALERT: The Schall Law Firm Announces It is Investigating Claims Against Amyris, Inc.
- 07/16/2020
|
Amyris (NASDAQ:AMRS) Downgraded by ValuEngine to “Hold”
- ValuEngine downgraded shares of Amyris (NASDAQ:AMRS) from a buy rating to a hold rating in a research report released on Tuesday morning, ValuEngine reports. Other equities analysts have also recently issued reports about the stock. Oppenheimer assumed coverage on shares of Amyris in a research report on Friday, June 5th. They set a buy rating […]
- 07/15/2020
|
INVESTIGATION ALERT: Labaton Sucharow is Investigating Amyris, Inc. for Potential Securities Violations and Breach of Fiduciary Duty (NASDAQ: AMRS)
- WILMINGTON, DE / ACCESSWIRE / July 15, 2020 / Labaton Sucharow, a nationally ranked shareholder rights firm, is investigating potential securities violations and breach of fiduciary duty claims against ...
- 07/15/2020
|
Amyris Launches Plant-derived Sustainable Silica for Clean Beauty Applications
- Aprinnova, Inc., an Amyris, Inc. (Nasdaq: AMRS) joint venture, the leading supplier of high performance, clean beauty ingredients is commercializing a plant-derived silica made from sugarcane ashes. Silica is used widely in personal care and cosmetics. It is traditionally sourced from non-renewable sand dredging, which requires significant energy consumption and emits large amounts of C02. The new ingredient branded Biosilica™ can be used in foundations, creams, lotions and other applications as a sustainable and better performing alternative to traditional silica. In addition, it offers an alternative to microplastics which are being phased out of many cosmetic products.
- 07/15/2020
|
INVESTIGATION ALERT: Fields Kupka & Shukurov LLP Is Investigating Amyris, Inc. for Potential Breach of Fiduciary Duty Claims
- NEW YORK, NY / ACCESSWIRE / July 9, 2020 / Fields Kupka & Shukurov LLP is investigating potential breach of fiduciary duty claims involving the board of directors of Amyris, Inc. (NASDAQ: AMRS ). If you ...
- 07/09/2020
|
Implied Volatility Surging for Amyris (AMRS) Stock Options
- Investors need to pay close attention to Amyris (AMRS) stock based on the movements in the options market lately.
- 07/03/2020
|
Implied Volatility Surging for Amyris (AMRS) Stock Options
- Stocks Analysis by Zacks Investment Research covering: Amyris Inc. Read Zacks Investment Research's latest article on Investing.com
- 07/03/2020
|
COVID-19 Impact and Recovery Analysis - Global Synthetic Biology Market 2020-2024 | Evolving Opportunities with Amyris Inc. and Algenol | Technavio
- The Global Synthetic Biology Market will grow by $11.52 bn during 2020-2024
- 07/01/2020
|
Top Marijuana Stocks for July 2020
- The marijuana industry is made up of companies that either support or are engaged in the research, development, distribution, and sale of medical and recreational marijuana. Many big marijuana companies have continued to post sizable net losses as they focus on investing in equipment and revenue growth. Marijuana stocks, as represented by the ETFMG Alternative Harvest ETF (MJ), have dramatically underperformed the broader market over the past 12 months.
- 06/30/2020
|
Biossance Announces Clean Academy Impact Award and Partnership With Oceana
- Biossance, a pioneering clean skincare brand from Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, is pleased to announce The Clean Academy by Biossance Impact Award™ to discover and foster the growth of future sustainability and environmental leaders. The program officially launched on June 29 via a digital fireside chat with Create & Cultivate, featuring Biossance President Catherine Gore, Future Earth co-founder Stephanie Shepherd, and Katie Matthews, PhD, Chief Scientist at Oceana, Biossance's new charitable partner and an organization dedicated toward protecting and restoring oceans across the world.
- 06/30/2020
|
Low-Priced Amyris Could Surprise on the Upside
- A look at the charts of this small-cap provider of bioscience services.
- 06/29/2020
|
Low-Priced Amyris Could Surprise on the Upside
- During Thursday evening's Lightning Round segment of Mad Money one caller asked Jim Cramer about Amyris Inc. . "This is a very interesting story and I like it," replied Cramer. In the daily bar chart of AMRS, below, we can see that the shares have traded sideways for the past 12 months.
- 06/29/2020
|
18,000 Shares in Amyris Inc (NASDAQ:AMRS) Bought by Baird Financial Group Inc.
- Baird Financial Group Inc. purchased a new stake in Amyris Inc (NASDAQ:AMRS) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 18,000 shares of the biotechnology company’s stock, valued at approximately $46,000. A number of other hedge funds and other institutional investors also […]
- 06/24/2020
|
Top Stocks To Short During Current Market Sell Off
- If you’re looking for some hedges for your portfolio or are looking to shift against the market, our deep learning algorithms and AI technology have several Top Shorts for you today.
- 06/24/2020
|
Why Amyris Stock Popped 12.5% on Monday | The Motley Fool
- Sugary taste with zero calories sounds delicious to investors.
- 06/22/2020
|
Amyris Partners With AB Mauri North America To Reduce Sugar In Baking Products Using PURECANE™ Sweetener
- Amyris, Inc. (Nasdaq: AMRS), a leading biotechnology company in the Clean Health and Beauty markets and a top supplier of sustainable and natural ingredients, and AB Mauri North America, a global supplier of yeast and baking ingredients, jointly announced an exclusive multi-year agreement for the sale and purchase of Amyris' Purecane™ RebM zero-calorie sweetener for baking applications.
- 06/22/2020
|
Innovatus Appoints Geoffrey Duyk, M.D., Ph.D. to Its Life Sciences Advisory Board | | IT Business Net
- NEW YORK--(BUSINESS WIRE)--Innovatus Capital Partners, LLC ("Innovatus" or the "Firm"), an independent adviser and portfolio management firm with approximately $1.6 billion in asse
- 06/22/2020
|
Innovatus Appoints Geoffrey Duyk, M.D., Ph.D. to Its Life Sciences Advisory Board
- Innovatus Capital Partners, LLC (
- 06/22/2020
|
There’s A New Fermented, Zero Calories Sugar On The Market (and It Actually Tastes Like Real Sugar)
- Amyris's Purecane sugar substitute is made using fermentation to avoid some of the bitter off-notes associated with other sugar substitutes.
- 06/17/2020
|
Positive First Steps Show the Promise of Psychedelic Therapies
- NEW YORK, June 10, 2020 /PRNewswire via COMTEX/ --
NEW YORK, June 10, 2020 /PRNewswire/ -- Depression and PTSD are serious psychiatric disorders which happen...
- 06/10/2020
|
Pareteum Secures Another Expensive Lifeline - Sell The Rally (NASDAQ:TEUM)
- Company announces another ugly financing transaction. Discussing key terms and potentially outsized dilution. Toxic deal component with floor price set at just
- 06/10/2020
|
Amyris Announces Closing Of $200 Million Private Placement
- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced the closing of its previously announced private investment in public equity (PIPE) in the Company.
- 06/10/2020
|
Amyris Inc (NASDAQ:AMRS) Director Frank Kung Acquires 3,689,225 Shares
- Amyris Inc (NASDAQ:AMRS) Director Frank Kung acquired 3,689,225 shares of the stock in a transaction dated Friday, June 5th. The shares were bought at an average cost of $3.00 per share, with a total value of $11,067,675.00. Following the transaction, the director now directly owns 2,932 shares of the company’s stock, valued at $8,796. The […]
- 06/10/2020
|
Investing In These 8 Bioeconomy Sectors Could Create Up To 1.6M Jobs Lost To COVID
- Governments can create incentives to transition skilled workers from sectors hard-hit by coronavirus into more resilient industries that are better for the environment.
- 06/09/2020
|
RumbleOn Uses PPP to Maintain Generous Compensation - ValueWalk
- Joining them is RumbleOn, Inc. a company that secured a more than $5.1 million PPP loan last month and then quietly revealed in recent days
- 06/08/2020
|
The Bio Revolution is changing business and society - STAT
- The Bio Revolution is the use of CRISPR and other genetic engineering tools to treat diseases, make crops less vulnerable to climate change, and more.
- 06/08/2020
|
10 Basic Materials Stocks Moving In Friday's Pre-Market Session
|
Amyris Reports $200M Private Placement
|
Amyris Raises $200 Million From Private Placement
- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that it has successfully executed a binding funding agreement with leading institutional investors to raise $200 million at $3.00 per common share through a private investment in public equity (PIPE) in the Company. The offering includes 49% of common stock and 51% of preferred stock, convertible into common stock following stockholder approval. The private investment is subject to customary closing conditions.
- 06/04/2020
|
9 Basic Materials Stocks Moving In Thursday's Pre-Market Session
|
Shares of several basic material companies are trading higher after as equities continue to gain on optimism over an economic reopening as well as a smaller-than-expected drop in nonfarm payrolls.
|
31 Stocks Moving in Wednesday's Pre-Market Session
|
Edited Transcript of AMRS earnings conference call or presentation 8-May-20 1:00pm GMT
- Q1 2020 Amyris Inc Earnings Call
- 06/02/2020
|
33 Stocks Moving in Tuesday's Pre-Market Session
|
71 Biggest Movers From Yesterday
|
Stocks To Watch: 6 Big Movers With Upside
- Stocks Analysis by Harry Boxer covering: Pan American Silver Corp, Ballard Power Systems Inc, Apache Corporation, Owens-Illinois Inc. Read Harry Boxer's latest article on Investing.com
- 06/02/2020
|
Stock Market Wrap-Up: Why These 2 Under-the-Radar Stocks Jumped Monday
- Investors enjoyed modest gains on Wall Street to start the new week, with the markets reacting favorably to a lack of news on the geopolitical front. The Dow Jones Industrial Average (DJINDICES: ^DJI), S&P; 500 (SNPINDEX: ^GSPC), and Nasdaq Composite (NASDAQINDEX: ^IXIC) were all up in the neighborhood of half a percent. Amyris (NASDAQ: AMRS) and Coty (NYSE: COTY) aren't household names, but they made their shareholders a lot happier today.
- 06/01/2020
|
Amyris Shares Resume Trade, Stock Relatively Quiet Upon Resumption, Shares Up 55% For Session
|
Amyris Shares Spike Higher With High Volume, Shares Up 53%, Halted On Circuit Breaker
|
48 Stocks Moving In Monday's Mid-Day Session
|
Here's Why Amyris Is Soaring Today
- Shares of Amyris (NASDAQ: AMRS) soared as much as 20.9% today after an article on Seeking Alpha suggested the synthetic biology company could be the next Tesla. On the one hand, what investor wouldn't want to own the next Tesla? Shares of the electric vehicle manufacturer and energy pioneer have jumped 3,570% since the initial public offering (IPO).
- 06/01/2020
|
This Could Be the Next Big Pot Stock
- A more effective way of delivering CBD could unlock significant growth opportunities for this unknown small-cap.
- 06/01/2020
|
Global High-Intensity Sweetener Market is Projected to Grow at a CAGR of 2.3% during the forecast period 2020-2027
- Jun 01, 2020 (CDN Newswire via Comtex) --
The high-intensity sweeteners market is expected to grow from USD 1.91 billion in 2019 to USD 2.23 billion by 2027,...
- 06/01/2020
|
72 Biggest Movers From Friday
|
Synthetic Biology Market 2020-2024 | Investment in Synthetic Biology Process and Techniques to Boost Growth | Technavio
- The Global Synthetic Biology Market will grow by $ 11.52 bn during 2020-2024
- 06/01/2020
|
Top Marijuana Stocks for June 2020
- The marijuana industry is made up of companies that either support or are engaged in the research, development, distribution, and sale of medical and recreational marijuana. Many companies in the young industry are losing money as they invest heavily in equipment and growth. Marijuana stocks, as represented by the ETFMG Alternative Harvest ETF (MJ), have dramatically underperformed the broader market over the past 12 months.
- 05/29/2020
|
Top Marijuana Stocks on the NASDAQ for June 2020
- These are the NASDAQ-listed marijuana stocks with the best value, fastest growth, and most momentum for June.
- 05/28/2020
|
Penny Stocks to Watch for June 2020
- While markets appear to be poised for a downtick, these low-priced stocks could see gains over the coming weeks.
- 05/27/2020
|
Amyris Launches Safe Alternative To Talc-Based Baby Powder
- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced the launch of "Baby Cream to Powder" under its Pipette™ baby brand giving caring parents more choice and keeping babies safe.
- 05/21/2020
|
Amyris Reports Launch Of Safe Alternative To Talc-Based Baby Powder
|
Is Another Accounting Issue Brewing for Amyris?
- Investors are less than two years removed from a significant accounting discrepancy. A closer look at SEC filings reveals another potential cause for concern.
- 05/18/2020
|
Amyris Changes its 2020 Annual Meeting of Stockholders to Virtual Format
- Amyris, Inc. (Nasdaq:AMRS), a leading synthetic biotechnology company with leadership in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that, due to public health and safety concerns related to the COVID-19 pandemic, recommendations and orders from federal, state and local authorities, and to support the health and well-being of its stockholders, employees, and others, it will host its 2020 Annual Meeting of Stockholders (the "Annual Meeting") as a virtual-only meeting that will be held via live audio webcast.
- 05/15/2020
|
Is Amyris Finally Turning a Corner?
- Investors were pleased by relatively positive operating results in the first quarter of 2020. Can the synthetic biology company turn those results into a durable trend?
- 05/14/2020
|
Amyris Receives GRAS Validation by Medical Expert Panel for its New Health and Nutrition Ingredient
- Amyris, Inc. (Nasdaq:AMRS), a leading synthetic biotechnology company with leadership in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, announces that its first health and nutrition ingredient received a validation by a unanimous Panel of Medical Experts as Generally Recognized As Safe ("GRAS"). Following this successful validation, Amyris will submit an application for FDA GRAS approval of this ingredient (currently not being named due to partner's requirements), which has the highest level of purity available today at the lowest cost and is made from a sustainable production process using fermentation.
- 05/14/2020
|
Amyris: The Future, Accelerated
- The Coronavirus is accelerating the future. Amyris moves with incredible speed to launch a hit product. Latest quarterly results deliver on the promise of 60% g
- 05/12/2020
|
BRIEF-Amyris Inc Says Files For Offer And Sale Of Up To 35.51 Mln Shares Of Common Stock by The Selling Stockholders
- * AMYRIS INC SAYS FILES FOR OFFER AND SALE OF UP TO 35.51 MILLION SHARES OF COMMON STOCKBY THE SELLING STOCKHOLDERS - SEC FILING Source text : (https://bit.ly/2LooEbS) Further company coverage:
- 05/12/2020
|
78 Biggest Movers From Yesterday
|
6 Stock Charts To Watch: AMRS, CYTK, DRNA, LX, MRNA, VAPO
- Stocks Analysis by Harry Boxer covering: SPDR S&P 500, Amyris Inc, BioCryst Pharmaceuticals Inc, Cytokinetics Inc. Read Harry Boxer's latest article on Investing.com
- 05/12/2020
|
Amyris, Inc. (AMRS) CEO John Melo on Q1 2020 Results - Earnings Call Transcript
- Amyris, Inc. (NASDAQ:AMRS) Q1 2020 Earnings Conference Call May 8, 2020 09:00 ET Company Participants Peter DeNardo - Senior Director-Investor Relations and Cor
- 05/08/2020
|
Amyris Inc. (NASDAQ: AMRS) Q1 2020 Earnings Call Transcript | AlphaStreet
- Final earnings conference call transcript of Amyris Inc. - AMRS stock
- 05/08/2020
|
Amyris, Inc. Reports First Quarter 2020 Results
- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced financial results for its first quarter ended March 31, 2020.
- 05/08/2020
|
Amyris Q1 EPS $(0.280) Misses $(0.190) Estimate, Sales $29.000M Miss $34.510M Estimate
|
Amyris to Participate in the Oppenheimer 5th Annual Emerging Growth Conference on May 12
- Amyris, Inc. (Nasdaq:AMRS), a leading synthetic biotechnology company with leadership in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that management will be participating in the Oppenheimer 5th Annual Emerging Growth Conference, which will take place virtually on Tuesday, May 12, 2020. President and Chief Executive Officer John Melo, and Chief Financial Officer Han Kieftenbeld will host one-on-one meetings via teleconference throughout the day.
- 05/07/2020
|
The Future Of Fragrances Through The Eyes Of Maison Francis Kurkdjian
- What role and purpose will fragrances take as we begin to live in the "new normal?" Master perfumer Francis Kurkdjian and Maison Francis Kurkdjian Co Creator Marc Chaya share insights on the future of fragrances.
- 05/07/2020
|
Davy Asset Management Ltd Buys Cisco Systems Inc, Truist Financial Corp, The Scotts Miracle Gro ...
|
Amyris To Host First Quarter 2020 Financial Results Conference Call On May 8
- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biology solutions provider, owner of Clean Beauty consumer brands and provider of proprietary functional ingredients, today announced that the company will host a conference call for investors and analysts on Friday, May 8, 2020 at 6:00 a.m. PT (9:00 a.m. ET) to discuss its first quarter 2020 results.
- 05/04/2020
|
The company changing beauty the way fake meat changed food
- Total plant-based skincare, which is environmentally sound, is a big bet. Biossance, founded in conjunction with Bill and Melinda Gates, is hoping it pays off.
- 05/04/2020
|
50 Top Stock Picks That Billionaires Love 2020
- They say on Wall Street that if you want to make a small fortune, start by investing a large one.The billionaires and big-time money managers below all have fortunes of various sizes, and studying which stock picks they've chased with their capital ain't a half-bad idea. After all, there'
- 05/01/2020
|
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Amyris, Inc.- AMRS
- NEW YORK, NY / ACCESSWIRE / April 21, 2020 / Levi & Korsinsky announces it has commenced an investigation of Amyris, Inc. (NASDAQ:AMRS) concerning possible breaches of fiduciary duty. To obtain additional ...
- 04/21/2020
|
BRIEF-Amyris Receives Approval To Sell Its Fermented Sugarcane Reb M In Brazil And Canada
- * PRESS RELEASE - AMYRIS RECEIVES APPROVAL TO SELL ITS FERMENTED SUGARCANE REB M IN BRAZIL AND CANADA
- 04/20/2020
|
Amyris Receives Approval to Sell its Fermented Sugarcane Reb M in Brazil and Canada
- Amyris Inc. (NASDAQ: AMRS), a global science and technology leader of pure, sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced that it has received approval from both Brazilian and Canadian regulators to expand its distribution of its fermented sugarcane Reb M, branded as Purecane™ zero calorie sweetener in the US to both of these countries.
- 04/20/2020
|
Amyris Reports Receives Approval To Sell Fermented Sugarcane Reb M In Brazil, Canada
|
Goldman Sachs Group Inc. Trims Stock Holdings in Amyris Inc (NASDAQ:AMRS)
- Goldman Sachs Group Inc. lessened its stake in shares of Amyris Inc (NASDAQ:AMRS) by 31.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 307,496 shares of the biotechnology company’s stock after selling 142,564 shares during the quarter. Goldman Sachs Group Inc. […]
- 04/19/2020
|
Amyris Experiences Very Strong Sales Start with Pipette Hand Sanitizer for the Whole Family
- Amyris Inc. (NASDAQ: AMRS), a global science and technology leader of pure, sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced the full market launch and sales of its Pipette branded hand sanitizer as of April 9th. Pipette, Amyris' clean baby skincare brand, offers the new plant derived hand sanitizer to consumers on Pipettebaby.com in 8oz and soon 32oz and 2oz sizes.
- 04/13/2020
|
Amyris Announces Full Market Launch Of Pipette Brand Hand Sanitizer; Says During First Three Days After Launch, Sold Ove $1.5M Of and Sanitizer
|
KPCB XII Associates, LLC Buys Amyris Inc
|
Largest borrow rate increases among liquid names CLVS;UPRO;JNK;I;AMRS;SGMS;RSX;EWC;MNK
- Largest borrow rate increases among liquid names CLVS UPRO JNK I AMRS SGMS RSX EWC MNK
- 04/06/2020
|
Shares of several basic materials companies are trading higher, potentially rebounding from yesterday's weakness. NOTE: Equities appear mixed through the session following US jobs data.
|
Citigroup Inc. Boosts Stock Position in Amyris Inc (NASDAQ:AMRS)
- Citigroup Inc. raised its position in shares of Amyris Inc (NASDAQ:AMRS) by 271.8% during the 4th quarter, Holdings Channel reports. The firm owned 23,076 shares of the biotechnology company’s stock after buying an additional 16,870 shares during the quarter. Citigroup Inc.’s holdings in Amyris were worth $71,000 as of its most recent filing with the […]
- 04/01/2020
|
Shares of several basic material companies are trading lower amid market weakness as macro concerns continue to grow as a result of the coronavirus pandemic.
|
Amyris Scales Up in Response to High Need for Its Hand Sanitizer and Wipe Products
- Amyris, Inc. (Nasdaq:AMRS), a global science and technology leader of pure, sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced that initial production of its hand sanitizer has started with Allure Labs as its contract manufacturing and packaging partner. Amyris has also successfully replenished its popular baby wipes that have been out of stock in most channels as fast as they restock.
- 03/31/2020
|
Amyris Reports Initial Production Of Its Hand Sanitizer Started With Allure Labs
|
Largest borrow rate increases among liquid names OVV;FCEL;AMRS;PD;UVXY;BZUN;FSM;SSO;VGK
- Largest borrow rate increases among liquid names OVV FCEL AMRS PD UVXY BZUN FSM SSO VGK
- 03/27/2020
|
NRZ, TLRY among premarket gainers
- Granite Point Mortgage Trust (NYSE:GPMT) +104% on suspending Q1 dividend in move to conserve cash.MFA Financial (NYSE:MFA) +75% on cancelling dividend.Wanda Sports Group Company (NASDAQ:WSG) +55% afte
- 03/26/2020
|
Covid-19-related update - healthcare
- Twist Bioscience (NASDAQ:TWST) will collaborate with Vanderbilt University Medical Center to supply gene and antibodies for the development of COVID-19 treatments. Also, unit Twist Biopharma will prov
- 03/26/2020
|
Amyris Launches Leading Hand Sanitizer and Receives Initial Positive Result for Vaccine Adjuvant
- Amyris, Inc. (Nasdaq:AMRS), a global science and technology leader of pure, sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced that it is launching a hand sanitizer to help address the high demand triggered by COVID-19. Additionally, the company has completed initial testing of a leading vaccine adjuvant.
- 03/26/2020
|
Amyris Launches Leading Hand Sanitizer; Also Says Has Completed Initial Testing Of Leading Vaccine Adjuvant
|
Edited Transcript of AMRS earnings conference call or presentation 12-Mar-20 8:30pm GMT
- Q4 2019 Amyris Inc Earnings Call
- 03/25/2020
|
Shares of several steel and materials stocks are trading lower amid investor concerns about a global recession driven by the coronavirus. An economic slowdown would reduce demand for basic materials.
|
144 Biggest Movers From Friday
- Gainers
Contura Energy, Inc. (NYSE: CTRA) shares surged 64.7% to close at $4.89 on Friday. Contura is expected to release Q4 results on March 18.
Exterran Corporation (NYSE: EXTN...
- 03/16/2020
|
Amyris Announces Business Update And Outlook
|
Mid-Afternoon Market Update: Dow Surges Over 800 Points; Amyris Shares Slide
- Toward the end of trading Friday, the Dow traded up 3.84% to 22,013.72 while the NASDAQ rose 3.32% to 7,440.54. The S&P also rose, gaining 3.69% to 2,572.16. South Korea...
- 03/13/2020
|
88 Stocks Moving In Friday's Mid-Day Session
- Gainers
CorePoint Lodging Inc. (NYSE: CPLG) gained 55.6% to $5.29 after the company reported results for its fourth quarter.
OPKO Health, Inc. (NASDAQ: OPK) climbed 44.4% to $2....
- 03/13/2020
|
Mid-Day Market Update: Citi Trends Rises After Q4 Results; Inovio Pharmaceuticals Shares Plunge
- Midway through trading Friday, the Dow traded up 2.26% to 21680.64 while the NASDAQ rose 2.22% to 7,361.97. The S&P also rose, gaining 2.25% to 2,536.54. South Korea confirmed...
- 03/13/2020
|
Mid-Morning Market Update: Markets Open Higher; Jabil Misses Q2 Estimates
- Following the market opening Friday, the Dow traded up 3.29% to 21898.51 while the NASDAQ rose 3.87% to 7,480.52. The S&P also rose, gaining 3.70% to 2,572.35. South Korea...
- 03/13/2020
|
Fly Intel: Pre-market Movers OPK;VALE;JKS;JBL;ORCL;ADBE;AVGO;SLACK;INO;ZUO;AMRS
- Fly Intel: Pre-market Movers OPK VALE JKS JBL ORCL ADBE AVGO SLACK INO ZUO AMRS
- 03/13/2020
|
11 Basic Materials Stocks Moving In Friday's Pre-Market Session
- Gainers
• Intrepid Potash, Inc. (NYSE:IPI) stock increased by 23.66% to $1.15 during Friday's pre-market session.
• Sibanye Stillwater, Inc. (NYSE:SBSW) shares rose...
- 03/13/2020
|
30 Stocks Moving in Friday's Pre-Market Session
- Gainers
Can-Fite BioPharma Ltd. (NYSE: CANF) rose 56.3% to $2.00 in pre-market trading after declining over 12% on Thursday.
Intec Pharma Ltd. (NASDAQ: NTEC) rose 40% to $0.28...
- 03/13/2020
|
Analysts Offer Insights on Consumer Goods Companies: Amyris (AMRS) and Malibu Boats (MBUU)
- There's a lot to be optimistic about in the Consumer Goods sector as 2 analysts just weighed in on Amyris (AMRS) and Malibu Boats (MBUU) with bullish
- 03/13/2020
|
Analysts Offer Insights on Consumer Goods Companies: Amyris (NASDAQ: AMRS) and Malibu Boats (NASDAQ: MBUU)
- There’s a lot to be optimistic about in the Consumer Goods sector as 2 analysts just weighed in on Amyris
- 03/13/2020
|
Amyris shares are trading lower after the company reported worse-than-expected Q4 EPS and sales results.
|
Amyris shares are trading lower after the company reported worse-than-expected Q4 EPS and sales results.
|
Shares of several basic materials companies are trading lower amid the global coronavirus outbreak, which has disrupted economic growth and hampered the demand for basic materials.
|
Psychedelic Medicine Stocks Capture The Attention Of Investors
- Psychedelic medicine involves the use of psychedelic substances such as psilocybin (the chemical in magic mushrooms), MDMA, LSD, and ketamine to treat patients
- 03/06/2020
|
NVAX, INO among premarket gainers
- Digirad (NASDAQ:DRAD) +63% on Q4 results.Enzo Biochem (NYSE:ENZ) +50% on launch of coronavirus testing service.NanoViricides (NYSEMKT:NNVC) +34% on coronavirus drug progress.TEGNA (NYSE:TGNA) +28% on
- 03/06/2020
|
Amyris Highlights Presentation Of Clinical Data Showcasing Its Sugarcane Squalane
|
Amyris Reports Its PURECANE Brand Packets Now Available On Amazon.com, No Terms Disclosed
|
Amyris shares are trading higher. Not seeing any news to justify the price action.
|
Largest Insider Trades of the Week
- Gurus loaded up on Enterprise Products Partners, dumped Trinet Group Continue reading...
- 02/23/2020
|
Largest Insider Trades of the Week
|
Amyris Option Alert: Mar 20 $3 Calls at the Ask: 500 @ $0.5 vs 6013 OI; Earnings 3/16 After Close [est] Ref=$3.075
|
80 Biggest Movers From Yesterday
|
Quantitatively Short: A Piotroski Short Portfolio
- The Piotroski F-Score is used to find low-quality stocks for shorting purposes. I combine that with the Ohlson O-Score and Altman Z-Scores to narrow things down
- 02/13/2020
|
Amyris Names Han Kieftenbeld CFO
|
90 Biggest Movers From Yesterday
- Gainers
Myomo, Inc. (NYSE: MYO) shares jumped 88.6% to close at $24.50 on Wednesday. Myomo shares surged around 115% on Tuesday after the company's MyoPro was approved for...
- 02/06/2020
|
TrinityPoint Wealth, LLC Buys US Foods Holding Corp, iShares Russell –……… ETF, ...
|
68 Stocks Moving In Wednesday's Mid-Day Session
- Gainers
Myomo, Inc. (NYSE: MYO) shares climbed 118% to $28.31. Myomo shares surged around 115% on Tuesday after the company's MyoPro was approved for reimbursement by German...
- 02/05/2020
|
Shares of several basic materials companies are trading higher as unconfirmed reports of progress towards a coronavirus treatment lift investor sentiment and economic outlook. Recent coronavirus fears clouded the demand outlook for these products.
|
85 Biggest Movers From Yesterday
- Gainers
China Pharma Holdings, Inc. (NYSE: CPHI) shares climbed 96.5% to close at $0.92 on Monday after gaining 11.50% on Friday.
Gulf Resources, Inc. (NASDAQ: GURE) shares...
- 02/04/2020
|
Mid-Afternoon Market Update: NASDAQ Rises Over 1%; Anavex Life Sciences Shares Surge
- Toward the end of trading Monday, the Dow traded up 0.62% to 28,431.07 while the NASDAQ rose 1.28% to 9,267.72. The S&P also rose, gaining 0.87% to 3,253.52.
Leading and...
- 02/03/2020
|
61 Stocks Moving In Monday's Mid-Day Session
- Gainers
China Pharma Holdings, Inc. (NYSE: CPHI) shares jumped 88% to $0.88 after gaining 11.50% on Friday.
Artelo Biosciences, Inc. (NASDAQ: ARTL) shares climbed 50.3% to $3.05...
- 02/03/2020
|
Amyris shares are trading higher after the company announced the execution of a definitive agreement for up to an anticipated $70 million in debt reduction through the exercise of existing warrants and $42 million in new financing.
|
5 Specialty Chemicals Stocks Moving In Tuesday's Session
-
Gainers
• Gulf Resources, Inc. (NASDAQ:GURE) stock moved upwards by 347.9% to $3.05 during Tuesday's regular session.
• Amyris, Inc. (NASDAQ:AMRS) stock...
- 01/28/2020
|
Options Traders Expect Huge Moves in Amyris (AMRS) Stock
|
Antero Resources and Amyris among energy/materials gainers; Camber Energy leads losers
|
Highlights from SupplySide West | WholeFoods Magazine
- Part two of WholeFoods' coverage from SupplySide West gives an update on new partnerships, products and innovations.
- 10/22/2019
|
Amyris (AMRS) Q4 2018 earnings preview
- Renewables product company Amyris (AMRS) is set to report its fourth quarter and full-year 2018 results on Monday, March 18 after the market closes. The recent boom in the US cannabis market is expected to positively impact Amyris' performance in the future. Amyris stock had gained 18% so far this year, while it declined 4% in the past three months period.
- 03/15/2019
|
BRIEF-Temasek Holdings Reports 8.9 Pct Stake In Amyris Inc
- * TEMASEK HOLDINGS (PRIVATE) LIMITED REPORTS 8.9 PERCENT STAKE IN AMYRIS INC AS OF MAY 22, 2018 - SEC FILING
- 05/23/2018
|
BRIEF-Amyris Says Novvi LLC and Chevron Entered Agreement
- * AMYRIS SUSTAINABLE LUBRICANTS JOINT VENTURE COMPANY, NOVVI, AND CHEVRON ENTER AGREEMENT TO DEVELOP AND BRING TO MARKET NEW RENEWABLE BASE OIL TECHNOLOGIES
- 05/18/2018
|
BRIEF-Amyris Inc Files For Non-Timely 10-Q - SEC Filing
- * AMYRIS INC FILES FOR NON-TIMELY 10-Q - SEC FILING Source text: (https://bit.ly/2wL2c8m) Further company coverage: (Reuters.Briefs@thomsonreuters.com)
- 05/16/2018
|
BRIEF-Amyris Q1 GAAP Loss Per Share $1.79
- * AMYRIS CONTINUES STRONG MOMENTUM AND EXECUTION WITH 77% REVENUE GROWTH AND EXCEEDS GROSS MARGIN TARGET
- 05/14/2018
|
BRIEF-Amyris Inc Files For Non-Timely 10-K With U.S. SEC
- * AMYRIS INC FILES FOR NON-TIMELY 10-K WITH U.S. SEC Source text: (https://bit.ly/2H66fh4) Further company coverage:
- 04/02/2018
|
BRIEF-Amyris Reports Q4 Gaap Loss Per Share $0.17
- * AMYRIS REPORTS ANOTHER STRONG QUARTER WITH SOLID OPERATING PERFORMANCE AND 2017 REVENUE OF $143.4 MILLION UP 113% OVER 2016
- 03/15/2018
|
BRIEF-DSM acquires Brazilian production facility from Amyris
- * DSM expands strategic alliance with Amyris and acquires Brazilian production facility from Amyris
- 11/17/2017
|
BRIEF-Amyris posts Q3 GAAP loss of $1.14 per share
- * Amyris reports another strong quarter of product sales growth and expects strong finish for 2017
- 11/14/2017
|
BRIEF-Amyris files for offering of up to 26.2 mln shares of common stock by selling stockholders
- * Amyris Inc files for offering of up to 26.2 million shares of common stock by the selling stockholders - SEC filing Source text: (http://bit.ly/2zaU4Od) Further company coverage:
- 11/03/2017
|
BRIEF-Amyris Inc enters into agreement with Koninklijke DSM N.V.
- * Amyris enters into product development and production agreement with Royal DSM for human nutrition ingredient
- 10/05/2017
|
BRIEF-Amyris enters into second major product development with Royal DSM
- * Amyris Inc enters into second major product development and production agreement with Royal DSM
- 09/26/2017
|
BRIEF-Amyris Q2 loss per share $0.46
- * Amyris delivers another strong quarter with revenue of $25.7 million and product sales increase of 159% over 2nd quarter of 2016
- 08/10/2017
|
BRIEF-Vivo Capital VIII reports 9.9 pct stake in Amyris
- * Vivo Capital VIII LLC reports 9.9 percent passive stake in Amyris Inc as of August 2, 2017 - SEC filing Source text: (http://bit.ly/2vCkff7) Further company coverage:
- 08/08/2017
|
BRIEF-Amyris files for offer and sale of up to 42.27 mln shares
- * Amyris Inc files for offer and sale of up to 42.27 million shares of co's common stock by the selling stockholders - sec filing Source text: (http://bit.ly/2hwaLw0) Further company coverage:
- 08/04/2017
|
BRIEF-Amyris says second tranche of $50 mln in a private placement days is being led by a $25-mln investment from Koninklijke
- * Amyris announces agreements for $50 million in second tranche of equity financing, exceeding previous target of $95 million
- 08/03/2017
|
BRIEF-Amyris enters into first product development, production agreement with Royal DSM
- * Amyris enters into first product development and production agreement with Royal DSM for food and nutrition molecule
- 07/17/2017
|
BRIEF-Amyris, on June 30, 2017, company issued, sold an amended, restated note in principal amount of $3 mln to purchaser
- * Amyris Inc - on June 30, 2017, company issued and sold an amended and restated note in principal amount of $3.0 million to purchaser - sec filing
- 07/07/2017
|
BRIEF-Amyris and government of Queensland announced plans to develop a industrial biotechnology hub in Southeast Asia
- * Amyris Inc and government of Queensland, Australia announced plans to develop a industrial biotechnology hub in Southeast Asia Source text for Eikon: Further company coverage:
- 06/20/2017
|
BRIEF-Amyris announces reverse stock split
- * Amyris announces reverse stock split - delivering on strong product revenue growth and execution
- 06/06/2017
|
BRIEF-Amyris reports Q1 loss per share of $0.13
- * Amyris reports 164 pct product revenue growth over prior year & continued strong outlook
- 05/15/2017
|
Dow Jones News Today: Stocks Rise as Investors Eye Retail Earnings Reports
- The Dow Jones news today features stocks rising ahead of another round of retail earnings reports. Here's what's ahead for the stock market today, May 15...
- 05/15/2017
|
